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 Transcription factor (TF) proteins act as molecular mechanisms that modulate the 
initiation of the first step in the expression of genes, gene transcription. Currently, 
knowledge of the DNA-binding specificities and genes regulated by many TFs, including 
those of well-studied model organisms such as Escherichia coli and Thermus 
thermophilus, remains incomplete or lacking which renders gaps in the understanding of 
the regulatory networks and systems biology of many organisms. Cyclic-AMP receptor 
protein (CRP) regulators and fumarate and nitrate reduction regulator (FNR) proteins 
compose the CRP/FNR superfamily of TFs, a diverse subgroup of TFs in bacteria which 
regulate various gene expression programs. In the present work, a reverse-genetic 
technique involving the combinatorial selection technique Restriction Endonuclease 
Protection, Selection, and Amplification (REPSA) has been applied to study TTHA1359, 
one of the four CRP/FNR superfamily TFs in the model organism T. thermophilus HB8. 
A TTHA1359-binding consensus, 5’-A(T/A)TGT(G/A)A(N6)T(C/T)ACA(A/T)T-3’, was 
identified using REPSA to select DNA sequences that TTHA1359 preferentially binds, 
massively parallel sequencing to acquire the sequence information of these selections, 
and bioinformatics to discover TTHA1359-binding motifs from the acquired sequence 
information. TTHA1359-binding to the identified consensus was biophysically 
characterized, and TTHA1359 was found to bind the identified consensus with high 
affinity, KD of ~ 3.4 nM. Several potential regulatory binding sites for TTHA1359 were 
identified bioinformatically by mapping the TTHA1359-binding consensus to the T.
iv 
 
thermophilus HB8 genome. The findings of the present work should not only contribute 
to the knowledge of the DNA-binding specificity and genes regulated by TTHA1359 but 
also provide insight into the functionality of the applied reverse-genetic technique that 
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CHAPTER 1. INTRODUCTION 
Chapter 1.1 Bacterial Transcription Factors 
 Gene expression in prokaryotic and eukaryotic organisms begins with gene 
transcription, and in most prokaryotes and eukaryotes, substantial regulation of gene 
expression transpires during the initiation, elongation, and termination steps of gene 
transcription. Although many molecular mechanisms mediate this regulation, 
transcription factor (TF) proteins act as a major mechanism of regulating transcription 
initiation, binding to DNA and changing rates of gene transcription initiation from 
promoters, the sequences positioned upstream of genes where transcription initiation 
transpires.  
 Bacterial TFs function as critical constituents of signal transduction networks, 
sensing cellular and environmental conditions and appropriately altering the 
transcriptional program. Most bacterial TFs possess two structural domains: a DNA-
binding domain that recognizes specific DNA sequences and a second domain that 
regulates the activity of the DNA-binding domain.1,2 For some TFs, the secondary 
domain directly perceives cellular or environmental conditions through the binding of 
ligands, perhaps small molecules or metabolites, and adjusts the activity of the DNA-
binding domain accordingly.3 For other TFs, the secondary domain indirectly senses this 
information through an interaction with a partner protein.3  
Bacterial TFs act as global or local regulators depending on several aspects 
associated with their activities including the number of genes and the functional diversity
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of the genes they regulate.4 Generally, global TFs regulate the expression of many genes 
while local TFs regulate the expression of one to a few genes.4 Some TFs solely function 
as activators, upregulating gene transcription, or as repressors, downregulating gene 
transcription. Other TFs function as both, up- or downregulating gene transcription 
depending on different promoter contexts. Mechanistically, repressors can downregulate 
transcription by inhibiting RNA polymerase holoenzymes, the transcriptional machinery, 
from binding at promoters by inducing structural changes in DNA to block access to 
promoters or by binding promoter sequences overlapping those the holoenzymes 
recognize such as the -35 and -10 core promoter sequence elements.5 Activators can 
upregulate transcription by distorting promoter sequences to improve suboptimal spacing 
between core promoter elements or by interacting directly with both promoter sequences 
and RNA polymerase holoenzymes to recruit the transcriptional machinery to promoters.6 
In addition to these mechanisms, repressors can counter activators to downregulate 
transcription, and conversely, activators can antagonize repressors to upregulate 
transcription.7  
 Knowledge of the DNA-binding specificities and the genes regulated by bacterial 
TFs provides insight into not only the regulatory and biological roles of TFs but also the 
transcriptional regulatory networks and systems biology of bacteria. This knowledge, 
however, remains incomplete or lacking for many TFs in most, even model, bacteria. For 
example, ~ 100 of the ~ 300 encoded TFs within the ~ 4,300 genes of the well-studied 
model bacteria Escherichia coli K-12 lack as little evidence as a single TF binding  
site.1,8-10 Even for Thermus thermophilus HB8, a model thermophilic bacteria with as few 
as ~ 2,200 genes and ~ 70 encoded TFs, DNA-binding specificities, genes regulated, and 
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biological functions have been discovered for only a handful.11-22 Therefore, continuing 
to study bacterial TFs, discovering the DNA sequences they recognize, genes they 
regulate, and their regulatory as well as biological functions, is essential if the 
transcriptional regulatory networks and systems biology of E. coli, T. thermophilus, and 
other bacteria is to be fully comprehended.
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Chapter 1.2 Functional Characterization of Bacterial Transcription Factors  
 Genomic screens and bioinformatic analyses initially identify and classify 
bacterial TFs into families based on primary sequence similarities with previously 
characterized DNA-binding domains, the helix-turn-helix motif being the most common.1 
Typically, each family is named after its founding family member, and the functions of 
TFs assigned to a family are inferable from the function of the founding member or other 
characterized members of the family. However, not every family member behaves or 
regulates the same biological processes as the founding member or other members of the 
family. Therefore, an experimental exploration of their DNA-binding specificities and the 
genes they regulate is required to understand their regulatory and biological roles. 
 Many in vivo and in vitro methods have been developed or adapted for such 
purposes, identifying DNA-binding specificities and regulated genes from various 
genetic, biological, biochemical, or biophysical perspectives. For example, in vitro 
techniques can identify the DNA-binding affinity and specificity of a TF, how tightly a 
single DNA sequence is bound and how effectively DNA sequences are differentiated by 
a TF respectively.23 This specificity is frequently modeled as a position weight matrix 
(PWM) which in turn is often graphically depicted as a sequence logo.24,25 This logo 
illustrates a TF’s relative preference for each base at positions within its binding site and 
provides a tool to search a genome and identify potential regulatory binding sites and the 
genes the TF regulates. Alternatively, in vivo techniques attempt to identify the genes a 
TF regulates using more straightforward approaches such as directly isolating TFs bound 
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at promoters. They are particularly useful when the regulatory activity of a TF is to be 
studied during defined developmental stages or under various environmental conditions 
since they can indicate which binding sites are occupied by the TF under these 
conditions. Here, several classical and contemporary techniques applied to study the 
DNA-binding specificities and the genes regulated by TFs have been summarized.   
 The electrophoretic mobility shift assay (EMSA) is one of the oldest techniques 
applied to study protein-DNA interactions, probing these interactions by taking 
advantage of the impeded electrophoretic mobility of DNA complexed with protein 
compared to free DNA.26,27 In a traditional EMSA, labeled DNA is incubated with 
protein to attain chemical equilibrium before native, or non-denaturing, polyacrylamide 
gel electrophoresis (PAGE) is performed followed by detection of the labeled DNA.28 
Binding interactions between the DNA and protein slows DNA movement through the 
gel which yields an observable gel band shift.28 The traditional EMSA tolerates a 
spectrum of experimental parameters, and variations on the traditional EMSA further 
extend its applicational scope.28 However, EMSA is not without drawbacks which 
include the effects of the gel matrix environment on the stability of protein-DNA 
complexes and the discontinuity of binding equilibrium upon electrophoresis.28 
 Footprinting, another classic in vitro technique, investigates the DNA-binding 
specificities of ligands such as TFs by taking advantage of the local cleavage protection 
ligands confer to the DNA sequences they bind compared to those they do not.29-31 In a 
typical footprinting assay, test and control reactions are performed in which a cleavage 
agent digests a singly end-labeled DNA probe containing potential ligand-binding sites in 
the presence and absence of a DNA-binding ligand respectively.30,31 The DNA probe in 
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the control reaction is randomly digested, but the DNA probe in the test reaction is 
selectively cleaved because the ligand shields bound sites from cleavage.30,31 
Consequently, after resolving test and control reaction products by PAGE, bound sites are 
identified by comparing the gel band pattern of the two reactions for bands that are 
missing in the test reaction pattern.30,31 The sequences of these missing bands are then 
determined by comparing missing band locations with sequencing reaction products.30,31 
In contrast to EMSA, footprinting assays permit ligand-DNA interactions to be studied at 
binding equilibria, but EMSA is typically less difficult to perform since footprinting 
requires optimizing both ligand-binding and DNA-cleavage reactions to acquire the 
footprint signal.28,30,31 Additionally, gel resolution restricts the size of the footprinting 
DNA probe, affecting the number of potential binding sites screened during a single 
assay.30  
 In some bacteria, straightforward genetic approaches involving the manipulation 
of TF genes can be applied to identify the potential genes regulated by TFs.11-14,17,32 
These approaches rely on gene expression level changes, measured as changes in RNA 
transcript levels, caused by the overexpression, deletion, or inactivation of TF genes to 
identify the genes that TFs regulate. Genetic engineering techniques are initially applied 
to manipulate the genes that encode a TF, creating a mutant bacterial strain.11,12,32 Mutant 
and wild-type strains are then cultured, and the RNA transcripts expressed by each strain 
are extracted.11,12,32 These transcript samples are reverse transcribed to form 
complementary DNA (cDNA) sequences and uniquely labeled.11,12,32 Equivalent 
concentrations of labeled RNA or cDNA from each strain are exposed to a DNA 
microarray which has been spotted with single-stranded DNA sequences representing 
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individual genes from the wild-type strain and are permitted to hybridize with these 
spotted DNA microarray sequences.11,12,32 Hybrid cDNA-DNA complexes are then 
detected and compared for each strain to reveal the changes in gene expression caused by 
manipulating the genes encoding the TF and the potential genes regulated by the 
genetically manipulated TF (Figure 1).11,12,32 These approaches provide in vivo views into 
the regulatory activity of TFs and are applicable to studying the genes regulated by TFs 
during specific developmental stages or under different environmental growth conditions. 
However, several factors complicate the results obtained using these approaches. 
Overexpressing TFs can yield indiscriminate gene regulation due to nonspecific DNA-
binding. Deleting or inactivating TF genes can lead to the detection of false positives, 
resulting from the manipulated TF regulating one or more other TFs, and false negatives, 
resulting from minor changes in RNA transcript levels or from genes coregulated by 
multiple TFs. Additionally, not all bacteria have the required genetic tools to apply these 
approaches, and in bacteria with multiple genome copies, deleting or inactivating all 
genes encoding TFs can be challenging.  
 Chromatin immunoprecipitation (ChIP) is an alternative in vivo technique that can 
be applied to identify the binding sites of bacterial TFs and the genes they regulate by 
directly isolating genomic TF-DNA complexes for analysis.33,34 In a typical ChIP assay, 
bacteria are cultivated then chemically treated with formaldehyde to reversibly cross-link 
genomic TF-DNA complexes.33 After extracting and fragmenting genomic DNA by 
sonication, TF-specific antibodies are utilized to immunoprecipitate TF-DNA complexes 
of interest.33,34 Genomic DNA sequences bound to the TF are freed by reversing TF-DNA 
complex cross-linkages and are subsequently sequenced along with genomic control 
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Figure 1. Identifying the genes regulated by a TF through a genetic approach. Steps in a genetic approach involving the inactivation of the genes 
encoding a TF to identify the genes it regulates have been depicted. These steps include (i) cultivation of bacteria, (ii) isolation of RNA transcripts, 
(iii) reverse transcription and fluorescent labeling, (iv) microarray hybridization, and (v) scanning and data analysis. Spots considered significant 
or those with differential gene expression, green and red spots, are used to identify the genes regulated by the TF. Green spots, genes with higher 
expression in wild-type bacteria, indicate the genes potentially upregulated by the  TF, and red spots, genes with higher expression in mutant 
bacteria, indicate the genes potentially downregulated by the TF.  
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DNA by microarray (ChIP-chip) or high-throughput sequencing (ChIP-seq).33,34 Similar 
to the previous genetic approaches, ChIP assays can capture snapshots of the genes that 
TFs regulate during distinct developmental stages or under specific environmental 
conditions, but they can also provide a robust in vivo indication of the genes actually 
regulated by a TF since isolated DNA sequences contain TF-binding sites. While ChIP 
assays possess limitations, including the required quantity of cells for experiments and 
the poor resolution of TF-binding sites, ChIP techniques continue to be developed that 
improve upon the aspects of the standard assay, reducing these experimental 
limitations.35,36 However, being an immunoprecipitation technique, ChIP assays require 
TF-specific antibodies or genetically tagging the genes of TFs with epitopes for which 
specific antibodies exist which often requires additional time and expense.33,34  
 Protein-binding microarray (PBM) assays offer a high-throughput in vitro method 
for identifying the DNA-binding specificities of TFs and other DNA-binding 
proteins.37,38  A PBM assay, as its name suggests, utilizes a DNA microarray spotted with 
double-stranded DNA sequences. Purified TF, native or epitope-tagged, is exposed to 
microarray sequences, enabling the formation of TF-DNA complexes.37,38 These TF-
DNA interactions are detected and quantified using TF- or epitope-specific antibodies 
linked to single fluorophores, revealing the DNA sequences preferentially bound by a TF 
as a measure of fluorescence intensity.37,38 Currently, a universal PBM is available for 
screening TF sequence specificity, encompassing the variation of every predicted 10-base 
pair (bp) sequence.38,39 While extensive, some TFs recognize DNA sequences longer than 
10 bp, rendering it difficult to comprehensively identify their DNA-binding specificities 
using PBMs.39 Additionally, some TFs require cofactors, post-translational modifications, 
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or interactions with partner proteins to bind DNA specifically which complicates using 
PBMs to identify their specificities.39  
 Combinatorial in vitro selection methods, including systematic evolution of 
ligands by exponential enrichment (SELEX), selected and amplified binding (SAAB), 
and cyclic amplification and selection of targets (CASTing), can also be applied to 
identify the DNA-binding specificities of TFs.40-43 These techniques typically use ligands 
such as TFs in repetitive nucleic acid selection, isolation, and amplification cycles to 
elucidate ligand-nucleic acid specificity.40-43 In these methods, a ligand is initially 
incubated with a nucleic acid selection template library containing randomized nucleic 
acid sequences for probing preferred ligand binding.40-43 An affinity- or physical-based 
technique is then applied to separate ligand-nucleic acid complexes formed during the 
incubation from unbound sequences.40-43 These complexed nucleic acids are then 
amplified and utilized as the input nucleic acid for a subsequent cycle.40-43 Repeating 
these steps enriches for nucleic acid sequences preferentially bound by the ligand (Figure 
2).40-43 These techniques have yielded useful binding information for an assortment of 
ligands, and additional adaptations and variations, SELEX serial analysis of gene 
expression (SELEX-SAGE) and high-throughput SELEX (HT-SELEX) for example, 
have expanded the utility of these techniques as research tools in biochemistry and 
molecular biology.44,45 However, the affinity- or physical-based steps used to separate 
complexed from free nucleic acid present potential obstacles when studying some ligand- 
11 
 
Figure 2. Selecting preferred ligand-binding DNA sequences by cyclic amplification and 
selection of targets (CASTing). Steps in CASTing have been depicted as a representative 
illustration of general combinatorial selection technique methodology. These  include (i) complex 
formation, (ii) antibody association, (iii) complex purification, (iv) PCR amplification, and (v) 
repetition steps to not only select but also enrich for sequences that a ligand preferentially binds.  
12 
 
nucleic acid interactions, particularly when minute differences in physical properties exist 
between complexed and free sequences and when ligands lack the amenability of an 




Chapter 1.3 Identifying Preferred DNA-binding by Restriction Endonuclease 
Protection, Selection, and Amplification 
 Pioneered by the Van Dyke Laboratory, restriction endonuclease protection, 
selection, and amplification (REPSA) is an alternative in vitro combinatorial selection 
method that can be applied to identify the binding specificities of TFs.46 REPSA selects 
the DNA sequences a ligand preferentially binds using a methodology like that of other 
combinatorial selection techniques, but this technique relies on ligand-dependent 
protection of bound DNA sequences from cleavage by type IIS restriction endonucleases 
(IISREs) to select preferred DNA-binding sequences and eliminate rejected sequences.46  
 Independent DNA recognition and cleavage domains enable IISREs to recognize 
DNA with sequence specificity yet non-specifically cleave DNA at a defined distance 
and, typically, in an asymmetric direction from the recognition site.47 REPSA exploits 
these distinctive cleavage properties by utilizing a double-stranded DNA selection 
template containing a randomized internal DNA core and defined flanking sequences 
with IISRE recognition sites that are oriented so that cleavage occurs within the 
randomized core (Figure 3).46 Thus, unlike other combinatorial selection techniques, 
REPSA does not require a physical- or affinity-based step to separate selected and 
rejected template sequences because IISREs are used to eliminate rejected sequences 




Figure 3. Type IIS restriction endonucleases and selection template ST2R24 structure in REPSA. (A) Selected IISREs used in 
REPSA with respective asymmetric distances to cleavage sites. (B) Structure of the selection template ST2R24  used in REPSA 
containing standard template 2 (ST2) flanks and a randomized 24-bp (R24) core. Brackets indicate respective IISRE recognition 
sequences within ST2 flanks. Arrows indicate corresponding IISRE cleavage sites within the randomized template core. 
Horizontal arrows represent primer sequences used to PCR amplify templates. Asterisks indicate the presence of a single IRDye 
700 fluorophore label at the 5’-end of primer ST2R and selection template ST2R24. N represents a random nucleotide.  
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 A round of REPSA involves several steps: the incubation of a DNA selection 
template library with a ligand to form ligand-DNA complexes, IISRE cleavage of 
unbound selection templates, and amplification of ligand-bound templates by PCR for the 
subsequent round of REPSA (Figure 4).46 Repetition of REPSA continues until the 
detected enrichment of ligand-preferred DNA-binding sequences.46 Highlighting its 
utility as a research tool, REPSA has been applied to identify the DNA-binding 
specificities for ligands including small molecules, oligonucleotides, and proteins 
including TFs.19-22,48-53 However, selecting low and high affinity sequences as well as 
intermediate affinity sequences to inclusively identify ligand-binding specificity using 
REPSA requires the optimization of both ligand-binding and IISRE cleavage reaction 
parameters.46 Additionally, REPSA often requires switching from the use of one IISRE to 
another between rounds to reduce the selection of sequences recognized by IISREs.46,48 
Due to differences in the DNA-binding kinetics and cleavage efficiencies of IISREs, this 
typically requires optimizing REPSA reaction parameters at least twice if not more.   
16 
 
Figure 4. Selecting preferred ligand-binding DNA sequences by restriction endonuclease 
protection, selection, and amplification (REPSA). REPSA involves (i) complex formation, (ii) 
IISRE cleavage, (iii) PCR amplification, and (iv) repetition steps to select and enrich for 
sequences that a ligand preferentially binds.  
17 
 
Chapter 1.4 The CRP/FNR Transcription Factor Superfamily 
 Cyclic adenosine monophosphate (cAMP) receptor protein (CRP) regulators and 
fumarate and nitrate reductase regulatory (FNR) proteins together compose the CRP/FNR 
superfamily of TFs that primarily activate gene expression programs in response to a 
spectrum of cellular and environmental signals.54 Members of the superfamily are 
structurally characterized by a C-terminal domain with a helix-turn-helix DNA-binding 
motif and large N-terminal domain that typically binds a ligand or cofactor.54  
Currently, most insight into the CRP/FNR superfamily derives from research on the 
founding and representative members of the superfamily, E. coli CRP (CRPEc) and FNR 
(FNREc).  
  CRPEc is a two hundred and nine residue protein with a C-terminal helix-turn-
helix DNA-binding domain and an N-terminal domain with a binding site for cAMP.55,56  
This site functions as the primary cAMP-binding site while a site that lies between the N- 
and C-terminal domains functions as a secondary binding site for cAMP.55 These binding 
sites possess respective micromolar and millimolar affinity for cAMP.57-59 The active 
DNA-binding form of CRPEc is a dimer with cAMP bound at the primary binding site of 
each monomer.57-59 By comparison, cAMP-free CRPEc dimer and CRPEc dimer with 
cAMP bound at both primary and secondary binding sites have significantly reduced 
DNA-binding activity.57-59 CRPEc acts primarily as a global activator in E. coli that binds 
and directly upregulates the transcription initiation rate of hundreds of genes generally 
associated with the movement and metabolism of alternative carbon sources.4,60,61
18 
 
Currently, two hundred and seventy-one binding sites are listed for CRPEc in RegulonDB, 
a database repository for information on gene expression regulatory networks in E. coli.10 
Extracting and submitting these sequences to the online motif analysis program Multiple 
Em for Motif Elicitation (MEME) yields the DNA-binding consensus motif of CRPEc 
(Figure 5A1).10,62 CRPEc recognizes 22-bp stretches of DNA and exhibits high affinity for 
its 22-bp consensus sequence (Figure 5A2).63 
 FNREc, is a two hundred and fifty residue protein with a C-terminal helix-turn-
helix DNA-binding domain and an N-terminal domain that senses intracellular redox 
conditions through interactions with iron-sulfur clusters.64-68 FNREc switches between an 
inactive conformation as a monomer and an active conformation as a homodimer 
depending on the oxidative state of E.coli.65-68 Aerobic conditions promote the inactive 
monomer conformation while anaerobic conditions promote the active homodimer 
conformation by reducing and oxidizing the state of the associated iron-sulfur cluster 
respectively.65-68 Active FNREc functions as a global regulator that primarily activates the 
transcription of genes associated with anaerobic energy metabolism and to a lesser extent 
represses genes associated with aerobic energy metabolism.4,69-72 Currently, eighty-eight 
binding sites are listed in RegulonDB for FNREc.
10 Extracting and submitting these 
sequences to MEME for motif analysis as with CRPEc yields the DNA-binding consensus 
motif of FNREc (Figure 5B1).
10,62 Its minimal 14-bp consensus sequence shares 
similarities with that of CRPEc (Figure 5B2).
73,74 
 As mentioned previously, TFs can mechanistically activate transcription at 
promoters by binding promoter DNA and directly engaging RNA polymerase  
19 
 
Figure 5. DNA-binding consensus motifs and sequences for the transcription 
factors CRPEc and FNREc. (A) CRPEc and (B) FNREc consensus motifs (1) and 
consensus sequences (2). Consensus motifs, represented as sequence logos, were 
obtained from MEME analysis of the currently listed binding sites for CRPEc and 
FNREc in RegulonDB.10  
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holoenzymes to recruit the transcriptional machinery.75 The two simplest forms of the 
mechanism, termed Class I and Class II transcriptional activation, require only one TF  
bound at a single site for activation.75 This terminology was initially applied to describe 
simple CRPEc-dependent activation mechanisms at promoters and now extends to 
describe the activation mechanisms of other TFs.6,75 
 A TF that promotes transcription from a binding site positioned upstream of the    
-35 core promoter element activates through the Class I mechanism, engaging the C-
terminal domain of one or both RNA polymerase holoenzyme α-subunits to upregulate 
transcription initiation.75,76 Alternatively, a TF that upregulates transcription from a 
binding site that overlaps the -35 core promoter element activates through the Class II 
mechanism, primarily contacting the RNA polymerase holoenzyme σ subunit to 
upregulate transcription initiation.75,77 Class I and Class II activation efficiency appears 
dependent to a significant extent on the spacing of binding sites for TFs relative to core 
promoter elements due to the helical nature of duplex DNA.78,79 Studies on TF binding 
site spacing have demonstrated that an optimal TF binding site aligns a TF with core 
promoter elements along the double helix of DNA and that displacing an optimal TF 
binding site by even 1 bp is sufficient to reduce the activation efficiency of a TF.78,79 For 
Class I activation, a TF bound at a site centrally positioned approximately 51.5, 61.5, 
72.5, 82.5, or 92.5 bp upstream, sites separated by integral turns of the helix, can activate 
transcription with the greatest activation efficiency transpiring at positions 61.5 and 72.5 
bp upstream.78,79 For Class II activation, the optimal TF binding site corresponds to an 
upstream central position at 41.5 bp.78 
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Chapter 1.5 CRP/FNR Superfamily Transcription Factors in T. thermophilus HB8 
 Thermophilic organisms, thriving in environments of extreme heat, constitute a 
subgroup of extremophilic organisms, flourishing in environments of at least one 
extreme. Characteristically, proteins and enzymes expressed by thermophilic organisms, 
such as those expressed by T. thermophilus HB8, possess relatively higher intrinsic 
thermostability and function optimally at elevated temperatures, and as a result, they are 
of significant interest to biotechnology and industry as well as structural biology.80 
 Discovered in Japanese thermal spas, gram negative T. thermophilus HB8 can 
grow at temperatures as relatively cold as 47° to as hot as 85°C with an optimal growth 
temperature range of 65°-72°C.81,82 As a polyploid bacterium, T. thermophilus HB8 
maintains multiple copies of a 1.85 mega-bp circular chromosome (TTHA); a 257 kilo-bp 
megaplasmid, pTT27 (TTHB); and a 9.3 kilo-bp miniplasmid, pTT8 (TTHC).83 This 
bacterium is the subject of the Structural and Functional Whole-Cell Project undertaken 
by the research institute RIKEN in Japan (http://thermus.org/).84 This structural genomics 
project pursues the structural and functional characterization of all highly ordered T. 
thermophilus HB8 proteins with the aim of understanding all the biological phenomena 
of this bacterium (see previous link).84 Due to its smaller proteome size, the 
thermostability of its proteins, the increased aptitude of its proteins to crystalize, and the 
ability to genetically manipulate its genome, T. thermophilus HB8 was selected as the 
subject of the project.84
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 Screening of the T. thermophilus HB8 genome has identified proteins TTHA1359, 
TTHA1437, and TTHB099 as CRP family members and protein TTHA1567 as an NtcA 
family member, a family of TFs within the CRP/FNR superfamily functioning in global 
nitrogen assimilation in cyanobacteria.54 Currently, regulatory and biological functions 
have been assigned to only the CRP family members.11-13,16 A review of these roles for 
these proteins has been provided here.  
 TTHA1437 was the first T. thermophilus HB8 CRP family member studied and 
was designated T. thermophilus HB8 CRP due to its primary sequence and biochemical 
attributes.11-13,16 It is a two hundred and sixteen residue protein that forms a homodimer 
in solution and binds cAMP based on the findings of gel filtration chromatography, light 
scattering photometry, and protease sensitivity experiments.11 Inactivating the TTHA1437 
genes in T. thermophilus HB8 has no apparent effect on T. thermophilus HB8 growth, 
and therefore, the TTHA1437 gene is considered dispensable for the train.11 Six T. 
thermophilus HB8 gene promoters are activated by TTHA1437 in a mechanism 
dependent on cAMP.11 These gene promoters were initially identified using a genetic 
approach involving the inactivation of TTHA1437 genes in T. thermophilus HB8 and the 
comparison of gene expression levels for wild-type and TTHA1437-inactivated T. 
thermophilus HB8 strains.11 They were then validated using in vitro run-off transcription 
assays which demonstrated they were upregulated in a TTHA1437-dependent, cAMP-
dependent mechanism.11 Genes associated with these promoters were found to encode 
clustered regularly-interspaced short-palindromic repeat (CRISPR)-associated (Cas) 
proteins, proteins with potential roles in DNA replication and transcriptional regulation, 
and several proteins with no known function.11 The DNA-binding consensus 5’-
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(C/T)NNG(G/T)(G/T)C(A/C)N(A/T)NNTCACAN(G/C)(G/C)-3’ was predicted for 
TTHA1437 from the sequences of these six gene promoters.11 
 Currently, TTHA1359 is the most extensively studied T. thermophilus HB8 CRP 
family member.11-13,16 It is a two hundred and two residue protein with the alternative 
name of stationary phase-dependent regulatory protein (SdrP) due to its elevated gene 
transcript level in the stationary phase of T. thermophilus HB8 growth and its function as 
a transcriptional regulator.12 Its conformation in solution is a homodimer, and its overall 
ligand-free dimeric crystal structure closely resembles that of CRPEc with cAMP 
complexed at both primary and secondary cAMP-binding sites.12,55 Inactivating the genes 
encoding TTHA1359 in T. thermophilus HB8 slightly impairs the growth of T. 
thermophilus HB8 and its ability to cope with oxidative stress.12  
 TTHA1359 activates sixteen T. thermophilus HB8 promoters whose genes encode 
proteins that function in redox control, transcriptional regulation, RNA metabolism, DNA 
and protein repair, and the supply of energy and nutrients.12,13 Eight of these gene 
promoters were initially identified using a genetic approach involving the inactivation of 
TTHA1359 genes in T. thermophilus HB8 and the comparison of gene expression levels 
for the wild-type and TTHA1359-inactivated T. thermophilus HB8 strains.12 They were 
then validated using in vitro run-off transcription assays which demonstrated that they 
were upregulated in a TTHA1359-dependent, cAMP-independent mechanism.12 Because 
similarities were observed for structures of TTHA1359 and CRPEc, TTHA1359-binding 
sites were predicted for these eight promoters based on the consensus DNA-binding 
properties of CRPEc and the positions of CRPEc-binding sites associated with Class I and 
Class II activation mechanisms.12,55,56,75,85 From these predicted binding sites, the putative 
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DNA-binding consensus 5’-(A/T)(A/T)GTGA(N5-7)ACAC(T/A)(T/A)-3’ was derived for 
TTHA1359.12 The other eight gene promoters regulated by TTHA1359 were identified 
using an alternative genetic approach.13 In this approach, gene expression levels were 
collected from experiments with wild-type and gene-inactivated T. thermophilus HB8 
strains in which cultivation conditions such as duration, culture medium, and chemical 
treatment were varied.13 Expression levels were then analyzed for individual genes whose 
expression correlated with the expression of THA1359.13 Of those whose expression 
strongly positively correlated with that of TTHA1359, eight genes possessed promoter 
sequences resembling the putative TTHA1359-binding consensus site derived 
previously.12,13 These eight promoters were upregulated in vitro in a cAMP-independent, 
TTHA1359-dependent mechanism as with the eight gene promoters identified 
previously.13 From the binding sites of all sixteen promoters, the putative TTHA1359-
binding consensus 5’-TTGTG(N9)CNC-3’ was derived.
12,13 
 TTHB099 is the most recently studied T. thermophilus HB8 CRP family 
member.11-13,16 It is a one hundred and ninety-five residue protein that forms a 
homodimer in solution, and its overall ligand-free dimeric crystal structure resembles that 
of TTHA1359 and that of CRPEc with cAMP complexed at both primary and secondary 
cAMP-binding sites.12,16,55 It is considered to function biologically as a transcriptional 
activator of carotenoid biosynthesis in T. thermophilus HB8 based on the function of the 
nearly identical protein TT_P0055 encoded in the megaplasmid pTT27 of the closely 
related T. thermophilus HB27 strain.16
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Chapter 1.6 Objectives of the Present Work 
 REPSA has been previously applied in the Van Dyke laboratory as part of a 
reverse-genetic technique to study the potential regulatory and biological functions of 
TFs.19-22 Initially, REPSA is used in combination with next-generation sequencing and 
bioinformatic research tools to discover the DNA-binding specificities of TFs. These 
specificities are then bioinformatically mapped to genomes and bioinformatically 
characterized to identify potential regulatory binding sites for TFs. These potential sites 
are examined for binding by TFs in vitro, and validated binding sites are used to predict 
the genes regulated by TFs. Possible biological roles are then described for these TFs 
with respect to these validated genes. An end goal in the Van Dyke laboratory is the 
implementation of this reverse-genetic technique as an effective alternative approach to 
study putative TFs that lack characterization beyond mere family categorizations. 
Achieving this end goal requires a series of studies to demonstrate the effectiveness of 
this technique regarding the accurate determination of potential regulatory binding sites 
for TFs within subject genomes and the possible biological functions of TFs. Several of 
these studies have already been performed in which the reverse-genetic technique was 
implemented to identify the potential regulatory binding sites and possible biological 
roles of four transcriptional repressors from T. thermophilus HB8.19-22 For each of these 
TFs, a level of regulatory and biological characterization had already been established, 
allowing the accuracy of the reverse-genetic approach to be assessed by comparing its 
findings with those previously reported for these repressors.14,15,17-22
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 These studies not only corroborated what had been established previously but also 
reported additional findings that have contributed to a greater functional understanding of 
these TFs.14,15,17-22 In the present work, this reverse-genetic technique has been 
implemented to study TTHA1359-binding specificity and the genes that TTHA1359 
potentially regulates. This protein is an excellent next-step study subject for evaluating 
the effectiveness of the reverse-genetic for several reasons. TTHA1359 has been 
previously studied which permits the findings of the present work to be evaluated.12,13 As 
with the four previously studied TFs, TTHA1359 does not require a ligand to bind 
DNA.12,13,19-22 However, unlike the TFs studied previously, TTHA1359 functions as a 
transcriptional activator.12-15,17-22 Studying TTHA1359 should yield further insight into 
the functionality of the reverse-genetic technique and guide its future application to study 
other previously characterized TFs and eventually putative TFs.  
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CHAPTER 2. MATERIALS AND METHODS 
Chapter 2.1 Nucleic Acids and Stock Selection Template Library Preparation 
 RIKEN kindly supplied plasmid pET11a-TTHA1359 encoding TTHA1359 
protein for the project. Oligonucleotide precursors and primers were synthesized and 
purified by Integrated DNA Technologies and are listed in Appendix A (Table A1). Stock 
library selection template ST2R24 DNAs were prepared by assembling, PCR amplifying, 
and subsequently combining the PCR products of five individual 25 μL PCR reactions 
containing 1X Standard Taq Reaction Buffer (New England Biolabs®, NEB), 50 μM 
each dNTPs, 600 nM each ST2L and IRD7_ST2R primers, 1 ng single-stranded ST2R24 
template DNAs, and 25 U Taq DNA Polymerase. Cycling conditions consisted of 5 
cycles of 95°C for 30 sec, 60°C for 30 sec, and 68°C for 1 min; 1 cycle of 95°C for 30 
sec, 60°C for 30 sec, and 68°C for 1.5 min; and 1 final cycle of 95°C for 30 sec, 60°C for 
30 sec, and 68°C for 2 min. 
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Chapter 2.2 Expression and Purification of TTHA1359 Protein 
 Expression and purification of TTHA1359 protein followed a protocol similar to 
that previously established.19 Transformation of competent E. coli strain BL21 (DE3) 
bacteria with plasmid pET11a-TTHA1359 was followed by cultivation in 50 mL LB 
medium containing 100 μg/mL ampicillin at 37°C/250 rpm to an ODA600 of 0.6 before 
induction by supplementation of the growth medium with 1 mM IPTG. Induced bacteria 
were cultivated 5 hrs further then isolated by centrifugation (4000 x g, 15 min, 4°C). The 
obtained bacterial pellet was suspended in 1 mL cold 50 mM Tris-Cl (pH 8.1 at 25°C), 
200 mM NaCl, 0.2 mM EDTA, 2 mM DTT, and 1 mM PMSF. Suspended bacteria were 
lysed by incubation at 0°C with 0.3 mg/mL supplemented lysozyme for 15 min followed 
by sonication (5 cycles, 3 W, 10 sec on/ 10 sec off, 0°C). After centrifugation (21,000 x 
g, 15 min, 4°C), soluble cell lysate was aspirated and incubated at 70°C for 15 min before 
centrifugation a second time (21,000 x g, 15 min, 4°C). Aspiration and dilution of the 
resulting supernatant in an equivalent volume of glycerol, ensuring homogenization by 
rocking at 4°C for 1 hr, yielded the purified TTHA1359 stock utilized in downstream 
experiments. The purified stock was stored between experiments at -20°C. The 
concentration of purified TTHA1359 protein prior to dilution in glycerol was determined 
by densitometric quantification against a BSA standard curve and estimated at 2.45 
mg/mL, corresponding to a purified TTHA1359 stock of 27.5 μM monomer or 55 μM 
dimer as calculated with the 22,317 Dalton molecular weight of TTHA1359 protein 
obtained from the UniProtKB database, entry Q5SIL0.86 Samples obtained during the 
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expression and purification of TTHA1359 were analyzed alongside PageRuler™ 




Chapter 2.3 Identification of a DNA-binding Consensus for TTHA1359 
 Rounds of REPSA were performed following a formerly outlined protocol.19 
REPSA selections were performed in 10 μL reaction volumes containing 1X CutSmart® 
Buffer (NEB), 4.515 ng (10 nM) selection template ST2R24 DNAs, and 34 nM 
monomeric or 17 nM dimeric purified TTHA1359 protein stock. TTHA1359 protein was 
diluted in cold 50 mM Tris-Cl (pH 8.1 at 25°C), 200 mM NaCl, 0.2 mM EDTA, 2 mM 
DTT, and 200 μg/mL BSA, and 0.2% wt/vol Tween 20 on ice prior to its addition to 
reactions. The initial REPSA selection reaction contained stock selection template 
ST2R24 DNAs while each subsequent round of REPSA contained the selection template 
ST2R24 DNAs that were selected and amplified during the previous REPSA round. The 
4.515 ng stock selection template ST2R24 DNAs (100 fmoles or 6.023 x 10
10
 molecules) 
used as the input for round one of REPSA was not considered sufficient to encompass all 
random 24-bp sequences possible for the selection template ST2R24 (4
24
2⁄ =1.4 x 1014), 
but it was considered sufficient to identify preferred TTHA1359-binding sequences based 
on REPSA selections with the four previously studied T. thermophilus HB8 TFs which 
were initiated with less than half the input of ST2R24 DNAs reported in the present 
work.19-22 During REPSA cycles, selection reactions were incubated at 55°C for 20 min 
then 37°C for 10 min with a IISRE, 0.8 U FokI or 2 U BpmI for the initial two or final 
three rounds respectively, added to the reactions at the 37°C incubation midpoint. 
Selection reactions were terminated by incubation below 0°C. Alongside selection 
reactions, two selection control reactions were run which were assembled without 
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TTHA1359 protein and IISRE (DNA control) or solely without TTHA1359 (IISRE 
control). REPSA selections were PCR amplified for 6, 9, and 12 cycles as before except 
the PCR reaction input for each was 1 μL REPSA-selected ST2R24 template DNAs, the 
concentrations of ST2L, IRD7_ST2R, and NEB Taq DNA Polymerase were doubled, and 
the thermocycling annealing and elongation temperatures were adjusted to 58°C and 
68°C respectively.19 REPSA rounds each ended with the assessment of selection and 
amplification reactions, performed by native PAGE and IR fluorescence after the 
protocol described previously.19 Equivalent 2 μL volumes of reactions and 6X loading 
solution prepared with 20% wt/vol dextrose, 0.9% wt/vol Orange G dye, 0.1% wt/vol 
SDS, and 66 mM EDTA then loaded on 1X Tris-borate-EDTA (TBE, pH 8.3 at 25°C), 
10% wt/vol polyacrylamide (19:1 acryl:bis) gels and electrophoresed at 5 V/cm for 10 
min then 15 V/cm for 30 min. REPSA selection and amplification reactions were 
visualized by LI-COR instrument IR fluorescence imaging, and quantification of 
amplification reactions determined by a Qubit double-stranded DNA high-sensitivity 
assay kit (Thermo Fischer Scientific) and Qubit 3 Fluorometer (Thermo Fisher Scientific) 
as before.19 REPSA was terminated after round 5 as an apparent population of 
TTHA1359-dependent, IISRE cleavage-resistant selection template ST2R24 DNAs was 
detected during the assessment of round 5 selection results (Figure 7).  
 Amplicon library DNAs were prepared from REPSA-selected round five 
amplified ST2R24 DNAs for massively parallel semiconductor sequencing by 
modification of the method outlined previously.19 A 2 μL aliquot of REPSA round 5 
DNAs was added to a 25 μL PCR reaction containing 1X Standard Taq Buffer, 150 μM 
each dNTPs, 200 nM each trP1_ST2L and A_BC06_ST2R primers, and 0.08 U Taq 
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DNA Polymerase (NEB). Cycling conditions were seven cycles of 95°C for 30 sec, 54°C 
for 30 sec, and 68°C for 1 min. Deviating from the previous method, 2 μL aliquots of 
PCR product were added to three individual 25 μL PCR reactions containing 1X 
Standard Taq Buffer, 150 μM each dNTPs, 200 nM each trP1_uni and A_uni primers, 
and 0.08 U Taq DNA Polymerase. Cycling conditions consisted of 6, 9, and 12 cycles of 
95°C for 30 sec, 55°C for 30 sec, and 68°C for 1 min. From each reaction, 2 μL aliquots 
were removed and assessed as described during rounds of REPSA. Results were 
visualized by UV exposure using a Gel Doc™ EZ (BIO-RAD) instrument after staining 
in 20 mL water containing 50 μg ethidium bromide. The resulting library of amplicon 
DNAs yielded by the 9-cycle PCR reaction, possessing the highest visible concentration 
and double-stranded to single-stranded ratio of amplicon DNAs, was selected and 
purified using a DNA Clean & Concentrator kit (Zymo Research). Massively parallel 
sequencing of the prepared and purified library of amplicon DNAs proceeded as 
described.19 
 Raw sequencing data was initially refined by the Sequencing1.java program as 
described while the first one thousand unique sequences of the resulting refined sequence 
set were manually identified due to the apparent removal from the web of the program 
applied previously to remove duplicate sequences, DuplicatesFinder v 1.1.19 The unique 
sequence set was uploaded to MEME v 5.1.1 for non-palindromic and palindromic 
consensus discovery.62 Motif discovery parameters were set at default except the 
maximum width of discovered motifs was restricted to 24 bp, corresponding to the width 
of the randomized core of selection template ST2R24 DNAs, and the palindromic filter 
was applied for the palindromic motif search. Resulting motifs with statistical 
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significance values, E-values, < 0.01 were analyzed. Data from the discovered, selected 
motifs such as statistical significances and number of sites contributing to the motifs were 
recorded, and graphical representations of the motifs were exported (Figure 9A, 9B). 




Chapter 2.4 TTHA1359-DNA Binding Assays 
 An EMSA was performed to validate the authenticity of the emergent REPSA-
selected TTHA1359-binding ST2R24 DNAs which generally followed the protocol that 
has been described previously.19 EMSA binding reactions were performed in 5 μL 
reaction volumes containing 0.5X Tris-acetate-EDTA (TAE, pH 8.4 at 25°C) 
supplemented to 1 mM EDTA, 0.2% wt/vol Tween 20, 2% wt/vol glucose, 0.5 μg BSA, 
and 10 nM IRD7-labeled REPSA round one and five PCR-amplified selections incubated 
with 0, 1, 10, 100, or 1000 nM TTHA1359 protein dimer. Binding reactions were 
assembled and equilibrated at 55°C for 5 min prior to the addition of TTHA1359 protein.  
Binding reactions were then incubated at 55°C for 30 min before they were directly 
loaded onto a 0.5X TAE, 10% wt/vol polyacrylamide (19:1 acryl:bis) gel. Loaded 
reactions were electrophoresed in 0.5X TAE buffer at 10 V/cm for 30 min. Results were 
visualized by IR fluorescence as described previously (Figure 8).19 
 Binding kinetics were determined between TTHA1359 and biotinylated DNAs by 
biolayer interferometry (BLI) essentially as described previously but with additional 
control reactions.19 TTHA1359-binding control, consensus, mutant consensus, and CRPEc 
consensus DNAs were PCR biotinylated and amplified for BLI assays in 50 μL reaction 
volumes containing 1X Standard Taq Reaction Buffer, 50 μM each dNTPs, 350 nM 
ST2L primer, 300 nM Bio_ST2R primer, 2 ng DNA template precursor, and 2 U Taq 
DNA Polymerase (Table A1). Cycling conditions consisted of 30 cycles of 95°C for 30 
sec, 58°C for 30 sec, and 68°C for 1 min. BLI assays were performed with an
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OctetQK (FortéBio) instrument at 37°C in 25 mM Tris-Cl (pH 8.1 at 25°C), 100 mM 
NaCl, 1 mM EDTA, and 0.05% Tween 20 buffer in 96-well microplates. For each assay, 
2 nM biotinylated DNA sequences were immobilized during a 20 min incubation on 
Streptavidin Dip and Read Biosensors (FortéBio) which were hydrated in buffer 5-10 
minutes at 25°C prior to each assay. Loaded biosensors were rinsed in fresh buffer for 5 
min to establish immobilized DNA baselines, then immersed for 5 min in buffer 
containing different dimeric TTHA1359 protein concentrations (5.7, 17, 51, 153, and 461 
nM), and finally washed for 10 min in fresh buffer. Biosensor data for each assay, 
recorded in wavelength shift (nm), was obtained every 1.6 sec. Besides the PCR 
amplified biotin-labeled control DNA sequence tested for nonspecific or weak binding, 
ST2_1359_ctrl, each assay included controls, assembled without TTHA1359 protein 
dimer and biotinylated DNA sequences (biosensor control) or TTHA1359 protein dimer 
(biosensor load control). Data from the control was subtracted point-by-point from the 
experimental biosensor data prior to data analysis. Binding kinetics were determined for 
each assay by non-linear regression analysis of association and dissociation biosensor 
data collected using protein concentrations of 5.7, 17, 51, and 153 nM TTHA1359 dimer 
using GraphPad Prism software as before (Table 1).19 Representative raw associative and 
dissociative step BLI data and calculated best-fit line traces for TTHA1359 and tested 
DNA sequences have been provided in the text (Figure 10) while the remaining plots 





Chapter 2.5 Identification of Potential Regulatory TTHA1359-binding Sites in 
the T. thermophilus HB8 Genome  
 Since the top non-palindromic motif discovered by MEME was a truncation of the 
consensus suggested by the motif, the motif was not directly imported into the program 
Find Identified Motif Occurrences (FIMO) as previously described.19,87 Instead, position-
dependent letter-probability matrix data from positions 6-16 of the top non-palindromic 
motif discovered by MEME was initially utilized to derive an extended 22-bp position-
dependent letter-probability matrix motif. A text file suitable for upload and utilization by 
FIMO was then written in MEME minimal motif format, containing the targeted version 
number of MEME, the extended motif alphabet and strand information, and the extended 
position-dependent letter-probability matrix motif (http://meme-suite.org/doc/meme-
format.html?man_type=web) (data not shown). The file was uploaded to FIMO v 5.1.1 
and utilized to scan the GenBank Thermus thermophilus HB8 universal identifier 13202 
version 210 database for potential binding sites with statistically significant p-values less 
than 0.0001. Potential binding sites selected for further bioinformatic analysis were 
limited to the identified potential binding sites with p-values less than 6 x 10-5 (Table 2). 
 Genomic sequence contexts, encompassing -210/+310 bp of these potential 
binding sites, were obtained from the Kyoto Encyclopedia of Genes and Genomes 
(KEGG) database.88 As explained in the next paragraph, some of these genomic 
sequences contexts have been provided in the text (Figure 11) while others have been 
provided in Appendix C (Figure C1). Potential binding sites located between or near
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bidirectionally oriented genes were examined individually, extracting the genomic 
sequence context in both orientations. Genes positioned near potential TTHA1359-
binding sites were noted (Table 2), and transcription unit information for these genes, 
whether they were transcribed as single units or as one of several genes in an operon, was 
ascertained through the BioCyc database collection (Table 2).89 Potential core promoter 
elements within the obtained sequence contexts were predicted by sequence context 
submission to the online bacterial promoter prediction program BPROM by Softberry 
(Figure 11, Figure C1).90  
 Initially, FIMO-identified potential binding sites with no identifiable core 
promoter elements were removed from further consideration. Potential binding sites were 
also excluded by limiting the distance between predicted transcription and known 
translation start sites of local genes to 100 bp. This was an arbitrary restriction as no 
comprehensive transcription start site data is currently available for T. thermophilus HB8. 
Of the remaining potential binding sites, those positioned downstream of predicted core 
elements were excluded from further consideration. Finally, potential binding sites with 
central positions greater than 100 bp upstream of predicted transcription start sites were 
excluded. Potential TTHA1359-binding sites which were excluded from further analysis 
have been provided in Appendix C (Figure C1). Potential TTHA1359-binding sites which 
were investigated for regulatory potential have been provided in the text (Figure 11). 
 Distances were calculated from transcription start sites to the center of remaining 
binding sites overlapping or upstream of predicted -35 core promoter elements (Table 3). 
Calculated distances were used to postulate binding site roles in transcriptional activation 
and corresponding activation mechanisms, either Class I or Class II, based on CRPEc-
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binding site mutational studies with regard to transcriptional activation.78,79 Roles in 
transcriptional repression were also postulated based on potential binding sites for 
TTHA1359 overlapping predicted core promoter elements.  
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CHAPTER 3. RESULTS 
Chapter 3.1 Expression and Purification of TTHA1359  
 Recombinant expression of TTHA1359 protein from T. thermophilus HB8 by 
induction of cultivated E. coli strain BL21 (DE3) transformed with plasmid pET11a-
TTHA1359 yielded significant TTHA1359 protein production as evidenced by analyzed 
culture samples harvested pre- and post-induction (Figure 6, Lanes 2 and 3). Expressed 
TTHA1359 protein was initially recovered in the cell lysate together with E. coli proteins 
after sonoporation of harvested cells treated with lysozyme (Figure 6, Lane 4). 
TTHA1359 protein was then purified from most contaminant E. coli proteins by 
subjection of the recovered cell lysate to high-temperature incubation (Figure 6, Lane 5). 
The identities of the few contaminant E. coli proteins that remained soluble during heat 
treatment have yet to be determined (Figure 6, Lane 5). Further purification to remove 
these remaining proteins was deemed unnecessary because previous applications with T. 
thermophilus HB8 proteins, expressed and purified similarly to TTHA1359, appeared 
unaffected by remaining contaminant proteins.19-22 This likely resulted from the dilutions 
of purified T. thermophilus HB8 proteins utilized in previous experiments effectively 
rendering remaining contaminant proteins as non-existent.19-22 The identity of the 
expressed and purified protein as TTHA1359 monomer was substantiated by the ~ 22 
kilodalton molecular weight of the presented protein band, consistent with the molecular 
weight of TTHA1359 monomer as determined its UniProtKB database entry, Q5SIL0 







Figure 6. Expression and purification of TTHA1359 protein. Image 
depicts samples obtained during TTHA1359 protein expression and 
purification as analyzed by 12% SDS-PAGE. Lanes were loaded with 
samples of protein ladder (lad), cultivated transformant E. coli in the 
exponential growth phase (exp), induced cultivated transformant E. coli 
post-incubation (ind),  recovered cell lysate following harvested  
bacterial cell membrane disruption  (lys), and recovered soluble cell 
content after high temperature purification (pur). Molecular weights of 
the protein ladder are indicated to the left of the figure. The protein band 
corresponding to TTHA1359 monomer is indicated to the right of the 
figure. Additional E. coli proteins that remained soluble during heat 
treatment (pur) have yet to be determined. 
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Chapter 3.2 Identification of a DNA-binding Consensus for TTHA1359  
 REPSA selections of TTHA1359-binding selection template ST2R24 DNAs were 
performed for a total five rounds before the detected emergence of an apparent 
population of TTHA1359-dependent, IISRE cleavage-resistant ST2R24 template DNAs 
(Figure 7). Rounds of REPSA initially relied on the IISRE FokI to interrogate 
TTHA1359-binding specificity, but selection of a minor population of ST2R24 DNAs 
with cleavage resistance against FokI, observed in the cleavage control and selection 
reactions during the assessment of REPSA round two selection results through image 
intensification (data not shown), required the switch to BpmI, an alternative IISRE, for 
the third round of REPSA. Unlike rounds one through four of REPSA, approximately 
half the input ST2R24 template DNAs in the selection reaction of REPSA round five 
were not digested by IISRE in the presence of 17 nM TTHA1359 dimer (Figure 7, Round 
5, Lane 3), suggestive of an enriched population of ST2R24 template DNAs to which 
TTHA1359 preferentially binds. Titration of REPSA round one and five amplified 
selections of ST2R24 template DNAs with TTHA1359 in an EMSA validated the 
enriched presence of preferred TTHA1359-binding DNAs (Figure 8). No mobility shift 
was observed for REPSA round one amplified DNAs across the range of TTHA1359 
dimer titrated (Figure 8, Lanes 1-5). However, an increasing mobility shift was observed 
for round five amplified DNAs beginning as low as equivalent concentrations of 
TTHA1359 dimer and DNAs (Figure 8, Lanes 6-10). Consequently, the cleavage 
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Figure 7. REPSA selection of a population of TTHA1359-binding 73-bp template ST2R24 DNAs. Each IR fluorescence image depicts selection 
reaction results from individual rounds of REPSA. Reactions in lanes 1-3 in each figure correspond to DNA controls prepared without TTHA1359 
or IISRE (-/-), cleavage controls including only IISRE (-/F or -/B representing FokI and BpmI IISRE inclusion respectively), and the selection 
reaction prepared with 17 nM dimeric TTHA1359 protein and IISRE (+/F or +F). Band designations: TI, intact ST2R24 template DNAs; TC, 
cleaved ST2R24 template DNAs; P, remnant 5’-labeled fluorescent ST2R primer.  
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Figure 8. Titration of amplified REPSA-selected 73-bp template ST2R24 DNAs from rounds  
one and five with TTHA1359. Reactions in lanes 1-5 and 6-10 contained 10 nM amplified 
selections from REPSA rounds 1 and 5 respectively. Reactions were incubated with either 0, 1, 
10, 100, or 1,000 (1K) nM dimeric TTHA1359 protein. Band designations: TF, Free ST2R24 




resistance of the intact population of ST2R24 template DNAs at REPSA round five was 
attributed to TTHA1359-binding as a result of the ST2R24 template DNAs possessing 
core sequences preferentially bound by TTHA1359.  
 Massively parallel sequencing of the synthesized amplicon library DNAs yielded 
9,516,545 total base reads with an incorrect base calling quality score, ≥ Q20, of 
8,631,131 and 158,313 reads of 60 bp average length. Sequencing runs with the amplicon 
library DNAs prepared from the REPSA-selected DNAs of the four previously studied T. 
thermophilus HB8 transcriptional repressors yielded 2-5 million total base reads, 1.5-3.5 
million ≥ Q20 quality scores, and 40,000-100,000 reads of average length 48-51 bp.19-22 
The improved sequencing results reported here were considered to be the result of the 
method in which the amplicon library DNAs were prepared for sequencing which 
differed than that used in the previous studies.19-22 The obtained 158,313 reads were 
reduced to 61,754 sequences of appropriate quality for further investigation by the 
applied Sequencing1.java refinement program. Manual examination of the first one 
thousand and five refined sequences yielded the first one thousand unique sequences as 
five sequences were identified as duplicates and removed. Submission of the identified 
unique sequence set to MEME yielded the top three non-palindromic and palindromic 
motifs each within the unique sequence set as determined by the program with the top 
two motifs discovered during each search possessing E-values, measurements of 
statistical significance, < 0.01 (Figure 9A, 9B). The top non-palindromic and palindromic 
motifs, corresponding to a 19-bp motif within a lengthier 24-bp pseudo- motif (Figure 
9A1) and a 24-bp motif (Figure 9B1), were discovered respectively within seven hundred 
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Figure 9. Discovered and derived TTHA1359-DNA binding motifs. The top two 
(A) non-palindromic and (B) palindromic motifs discovered by MEME analysis 
with statistically significant E-values < 0.01, represented as position-dependent 
letter-probability matrices. (C) The minimal TTHA1359-DNA binding consensus 
sequence derived from MEME discovered motifs. 
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and eighty-nine and eight hundred and ten of the unique one thousand sequence set input 





. Top secondary non-palindromic and palindromic motifs, 
corresponding to a 15-bp (Figure 9A2) and a 16-bp (Figure 9B2) motif, were respectively 
identified in one hundred sixty-seven and one hundred thirty-nine of the unique sequence 





. A minimal 20-bp inverted-repeat TTHA1359-binding consensus was derived 
primarily from the non-palindromic top motif (Figure 9C). Positions 1-7 and 14-20 of this 
THA1359-binding consensus (Figure 9C) were found to share significant similarities 
with positions 2-8 and 15-21 of the CRPEc consensus which correspond to twelve of the 
fourteen positions that CRPEc demonstrates strong sequence preferences (Figure 
5A2).63,91-93 Since TTHA1359 is a homodimer and its derived DNA-binding consensus is 




Chapter 3.3 Biophysical Characterization of TTHA1359-DNA Binding 
 BLI assays were performed to characterize the DNA-binding affinity of 
TTHA1359 for its identified consensus and CRPEc consensus sequences and to 
investigate its consensus-binding specificity. In these BLI experiments, real-time binding 
kinetics for select TTHA1359-DNA interactions were measured by recording wavelength 
shifts in biosensor-reflected, white-light interference patterns brought about by the 
interactions of TTHA1359 with biosensor-immobilized DNA.94 Raw wavelength shift 
data collected during these experiments at concentrations of 5.7, 17, 51, and 153 nM 
TTHA1359 dimer was used to calculate the DNA-binding kinetics between TTHA1359 
and the DNA sequences tested (Table 1). Raw data recorded at concentrations of 461 nM 
TTHA1359 dimer was excluded from these calculations because no significant or 
detectable binding was observed between TTHA1359 and the TTHA1359-binding 
control sequence except at 461 nM TTHA1359 dimer (data not shown). Raw associative 
and dissociative step BLI data and calculated best-fit line trace plots for TTHA1359 and 
its consensus, the CRPEc consensus, and control sequences have been provided here 
(Figure 10). The remaining plots for TTHA1359 and other DNA sequences have been 
provided in Appendix C (Figure C1). 
 High-affinity binding was observed between TTHA1359 and its consensus 
sequence, having a quick on rate, slow off rate, and a calculated apparent KD of ~ 3.4 nM 
with an R2 value > 0.95 (Figure 10A, Table 1). Individual single-point mutants were then 
introduced to positions 1-7 of the TTHA1359-binding consensus sequence (Figure 9C) to 
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con_wt ATTGTGACACACATCACAAT 457555 0.001577 3.447x10-9 0.9572 
con_p1  cTTGTGACACACATCACAAT ⸺⸺⸺⸺⸺⸺ Ambiguous ⸺⸺⸺⸺⸺⸺ 
con_p2 AgTGTGACACACATCACAAT 317173 0.01166 36.78x10-9 0.9820 
con_p3 ATgGTGACACACATCACAAT 215769 0.01867 86.53x10-9 0.9793 
con_p4 ATTtTGACACACATCACAAT ⸺⸺⸺⸺⸺⸺ Ambiguous ⸺⸺⸺⸺⸺⸺ 
con_p5 ATTGgGACACACATCACAAT ⸺⸺⸺⸺⸺⸺ Ambiguous ⸺⸺⸺⸺⸺⸺ 
con_p6 ATTGTtACACACATCACAAT 288341 0.02153 74.67x10-9 0.9766 
con_p7 ATTGTGgCACACATCACAAT 267033 0.006236 23.35x10-9 0.9843 
con _s5 ATTGTGAcacacTCACAAT ⸺⸺⸺⸺⸺⸺ Ambiguous ⸺⸺⸺⸺⸺⸺ 
con _s7 ATTGTGAcacacacTCACAAT ⸺⸺⸺⸺⸺⸺ Ambiguous ⸺⸺⸺⸺⸺⸺ 
CRP_Ec AAATGTGATCTAGATCACATTT 726387 0.0007341 1.011x10-9 0.8979 
ctrl ATACGAAAAACACACAC ⸺⸺⸺⸺⸺⸺ Ambiguous ⸺⸺⸺⸺⸺⸺ 
Lowercase nucleotides indicate single-point or spacing mutations from the wild-type 
consensus. KD, kon, and koff indicate the equilibrium dissociation, association rate, and 
dissociation rate constants respectively. Ambiguous indicates the absence of a significant 
observable or detectable binding event by BLI. 
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Figure 10. Representative BLI association and dissociation step raw data plots of TTHA1359-DNA binding. Graphs depict raw association and 
dissociation step data measured during BLI experiments with TTHA1359 and (A) ST2_1359_con_wt, (B) ST2_CRP_Ec, and (C) ST2_1359_ctrl 
biotinylated DNAs. These DNAs correspond respectively to wild-type TTHA1359-binding consensus, CRPEc-binding consensus, TTHA1359-
binding control sequences. Dots represent raw data points for these TTHA359-binding assays, and solid lines depict calculated best-fit lines for the 




characterize consensus sequence binding specificity, having mutated individual base 
positions to either the least represented or the non-complementary partner of the most 
highly represented base as identified by the top non-palindromic motif (Figure 9A1). 
Single-point mutant binding kinetics varied dramatically with single-point mutants 
introduced at positions 1, 4, and 5 yielding ambiguous binding under the applied 
experimental conditions (Table 1), suggesting a strong sequence preference at these 
positions. Results of mutations introduced at positions 2, 3, 6, and 7 were less detrimental 
as binding kinetics were actually attainable with observed binding affinity for the wild-
type TTHA1359-binding consensus ranging from ~ 6.5- to ~ 25-fold higher than binding 
affinities for single point mutants by calculated apparent KD value comparison (Table 1). 
Additional mutant consensus sequences, possessing either a truncated 5-bp or extended 7-
bp spacer sequence instead of the observed 6-bp spacer at positions 8-13 within the 
consensus sequence (Figure 9C), were tested and yielded ambiguous binding results, 
suggestive of a strict consensus sequence recognition spacing requirement under the 
reaction conditions specified (Table 1). Finally, as TTHA1359 and CRPEc were found to 
recognize similar sequences, TTHA1359-binding to the CRPEc consensus was 
investigated (Figure 5A2, Figure 9C, Figure 10B).63 TTHA1359 was found to have 
greater than 3-fold higher affinity for the CRPEc consensus over its identified consensus, 
having an apparent KD of ~ 1 nM with an R
2 value of ~ 0.9 (Figure 10B, Table 1). This 
increased affinity was attributed to a slight difference in the recognition sequences, 
corresponding to positions 2 and 19 within the TTHA1359 and 3 and 20 within the 
CRPEc consensus sequences, as well as differences in the 6-bp composition of the interior 
spacer regions of the two sequences (Figure 5A2, Figure 9C, Table 1).63 
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Chapter 3.4 Identification of Potential Regulatory TTHA1359-binding Sites in 
the T. thermophilus HB8 Genome 
 Having investigated TTHA1359-binding to its REPSA-selected consensus to 
ascertain the validity of its selected consensus, an extended TTHA1359 consensus motif 
which was derived from the top non-palindromic MEME motif discovered (Figure 9A1, 
positions 6-16) was submitted to FIMO to identify potential regulatory binding sites. The 
FIMO search yielded eighty-eight potential THA1359-binding sites within the T. 
thermophilus HB8 genome with p-values less than 0.0001 (data not shown). Selection of 
identified potential binding sites with p-values less than 6 x 10-5 narrowed the list of 
potential binding sites to the first fifty-nine for further analysis (Table 2). Cursory 
inspection of the selected potential sites using the KEGG database extended the list of 
sites to investigate to seventy-four, as fifteen of the fifty-nine selected sites were 
positioned near or within bidirectionally-oriented genes which were analyzed 
individually.  
 Initially, eleven of the seventy-four FIMO-identified potential binding sites for 
TTHA1359 were excluded from further analysis based on the absence of a predicted 
promoter, corresponding to potential sites upstream of genes TTHA0843, TTHB243, 
TTHA0583, and TTHA1326 (FIMO result nos. 5, 16, 36a, and 44 in Figure C1 and Table 
2) and downstream of genes TTHA1836, TTHA1236, TTHA1158, TTHA0486, 
TTHA1301, TTHA1352, and TTHA0030 (FIMO result nos. 18, 25, 26, 27, 32, 34a, and 53 
in Figure C1 and Table 2). In the absence of available comprehensive transcription start 
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site data for T. thermophilus HB8, distances between predicted transcription and known 
translation start sites of genes located proximally to potential TTHA1359-binding sites 
was restricted to 100 bp. Based on this restriction, potential binding sites downstream of 
genes TTHA0974, TTHC001, TTHA0910, TTHA0644, TTHA0030, TTHA0943, 
TTHA1848, TTHA0507, TTHB177, TTHA1632, TTHA0910, and TTHA0036 (FIMO result 
nos. 1, 3, 12, 13, 20, 23, 33, 35b, 38, 47, 48, and 54 in Figure C1 and Table 2) and 
upstream of genes TTHA0784, TTHA1730, TTHA1538, TTHB113, TTHA0055, TTHB088, 
TTHB177, TTHA1854, TTHA0303, TTHA0544, TTHA1398, and TTHA0205 (FIMO result 
no. 7, 21b, 29b 30, 31a, 37a, 38, 39, 42a, 45, 56a, 57a in Figure C1 and Table 2) were not 
investigated further. The limited genomic sequence context prevented the visual 
determination of predicted transcription start site distances to nearby translation start sites 
for potential binding sites positioned downstream of genes TTHA0910, TTHA0030, and 
TTHA0036 (FIMO result nos. 12, 20, and 54 in Figure C1 and Table 2). Returning to the 
KEGG database revealed there were no translation start sites within the distance restraint, 
and thus, these binding sites were excluded from further analysis. To the resulting thirty-
seven, only those potential TTHA1359-binding sites centrally positioned upstream or 
overlapping predicted core promoter elements were considered further which lead to the 
elimination of ten additional potential binding sites. These ten sites included potential 
sites identified upstream of genes TTHA0942, TTHA0936, TTHA1223, TTHA0084, 
TTHA0643, TTHA0643, TTHA0532 (FIMO result nos. 19, 22, 24, 41, 46, 49, and 52 in 
Figure C1 and Table 2) and downstream of genes TTHA1729, TTHA0344, TTHA1073, 
(FIMO result nos. 21a, 28, and 50 in Figure C1 and Table 2). For the remaining sites, an 
upstream limit of 100 bp from the central position of potential TTHA1359-binding sites 
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to predicted start sites of transcription was imposed based on the previously determined 
spacing requirements for CRPEc-dependent transcriptional activation at promoters in E. 
coli.78,79 This final restriction excluded potential binding sites upstream of genes 
TTHA1537, TTHA0056, TTHA1353, TTHA0304, TTHA1135, and TTHA1133 (FIMO 
result nos. 29a, 31b, 34b, 42b, 43, and 59 in Figure C1 and Table 2) from further analysis. 
These refinement steps excluded fifty-one potential TTHA1359-binding sites (Figure 
C1), yielding a total twenty-three FIMO-identified TTHA1359-binding sites which were 
analyzed for potential regulatory functions (Figure 11). 
 Of the remaining potential TTHA1359-binding sites with central positions 
overlapping or upstream predicted -35 core promoter elements, five sites were optimally 
positioned for TTHA1359 to bind and upregulate transcription based on calculated 
distances to predicted transcription start sites and information on binding site positions 
associated with simple CRPEc-dependent activation mechanisms (Table 3).
78,79 These 
sites corresponded to potential sites centered 41.5 bp from the predicted transcription 
start sites of TTHA0425, TTHA0584, and TTHA0770; 61.5 bp from the predicted 
transcription start site of TTHA0506; and 82.5 bp from the predicted transcription start 
site of TTHA0987 (FIMO result nos. 4, 36b, 58, 35a, and 6 in Figure 11 and Table 3). 
Potential TTHA1359-binding sites upstream of TTHA0425, TTHA0584, and TTHA0770 
gene promoters were found to correspond to optimal TF-binding positions associated 
with transcriptional upregulation by a Class II mechanism (Table 3).75,78,79 Potential 
binding sites upstream of TTHA0506 and TTHA0987 gene promoters were observed to 
correspond to optimal TF-binding positions associated with transcriptional upregulation 
by a Class I mechanism (Table 3).75,78,79 An additional potential regulatory binding site 
54 
 
for TTHA1359 was noted, centered at 93.5 bp upstream of TTHB089 (Table 3). 
However, since the transcriptional activity CRPEc when centrally bound 92.5 bp upstream 
of a transcription start site has been demonstrated to be minor, substantial upregulation of 
TTHB089 transcription by TTHA1359 at this potential binding site was considered 
unlikely to occur (Table 3).79 Potential binding sites were also noted upstream of 
TTHA0953, TTHA0446, TTHA0447, TTHA0533, TTHA0606 twice, and TTHA0206 
genes, but were considered unlikely to be regulatory due to their orientation on the DNA 
double-helix with respect to predicted core promoter elements (Table 3).78,79 
Interestingly, a considerable number of remaining potentially binding sites overlapped 
predicted core promoter elements (Table 3). These binding sites included those upstream 
of genes TTHA0080, TTHA0081, TTHA0954, TTHA0534, TTHA0109, TTHA0607, 
TTHA0607 again, TTHA1026, TTHA1399, and TTHA1133 (FIMO result nos. 9a, 9b, 10, 
14b, 17, 40b, 51b, 55, 56b, and 59 in Figure 11 and Table 3). Although a potential role as 
transcriptional repressor was not suggested by previous work with TTHA1359, the 
positioning of these sites with respect to predicted transcription start sites suggests a 










Table 2. FIMO-identified potential TTHA1359-binding sites in the T. thermophilus HB8 genome 
FIMO 
Result 
Loci Start End p-Value Q-value Sequence Position Local Gene(s) Operon 










3 Miniplasmid 1,503 1,524 1.78x10-8 0.0125 GAAAGTGAGATAACTCACATAT Intergenic TTHC001 1/1 
4 Chromosome 402,440 402,461 1.01x10-7 0.0532 TAAAGTGCTTTATTTCACAAAA Intergenic 



















8a Chromosome 418,352 418,373 3.97x10-7 0.105 AATTGTCAACGGGATTACGTAT  Intergenic TTHA0446 1/1 
8b Chromosome 418,352 418,373 3.97x10-7 0.105 ATACGTAATCCCGTTGACAATT Intergenic TTHA0447 1/5 
9a Chromosome 81,405 81,426 5.35x10-7 0.113 CCATGTGTTTTAGTTTACTTTA  Intragenic TTHA0080 1/2 
9b Chromosome 81,405 81,426 5.35x10-7 0.113 TAAAGTAAACTAAAACACATGG Intragenic TTHA0081 1/3 





11 Chromosome 932,531 932,552 5.88x10-7 0.113 TCTTGTACTTTTATTCACGATT Intergenic TTHA0987 1/1 
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12 Chromosome 871,755 871,776 1.69x10-6 0.298 ACTTGTCAGCAAAATTACGATG Intergenic TTHA0910 3/3 





14a Chromosome 496,704 496,725 3.11x10-6 0.471 GAAAGAGAATGTTAGCACATTT  Intergenic TTHA0533 1/2 
14b Chromosome 496,704 496,725 3.11x10-6 0.471 AAATGTGCTAACATTCTCTTTC Intergenic TTHA0534 1/2 
15 Chromosome 1,507,780 1,507,801 5.01x10-6 0.706 ATTTGGACGCAATTTCACTTTT Intragenic TTHA1584 3/3 

























21a Chromosome 1,622,533 1,622,554 1.35x10-5 1 AAAGGTGGGCAAAAAGACGTTT Intragenic TTHA1729 1/1 
21b Chromosome 1,622,533 1,622,554 1.35x10-5 1 AAACGTCTTTTTGCCCACCTTT Intragenic TTHA1730 1/3 



























27 Chromosome 456,182 456,203 1.69x10-5 1 CTGCGTGAGCTACCTCACCATT Intragenic TTHA0486 2/2 





29a Chromosome 1,464,992 1,465,013 1.74x10-5 1 TAATGTGCGCTATTTCCCAACT Intergenic TTHA1537 1/1 
29b Chromosome 1,464,992 1,465,013 1.74x10-5 1 AGTTGGGAAATAGCGCACATTA Intergenic TTHA1538 1/1 





31a Chromosome 54,523 54,544 2.08x10-5 1 ATCAGTGACATACGTGCCATTT Intergenic TTHA0055 1/2 
31b Chromosome 54,523 54,544 2.08x10-5 1 AAATGGCACGTATGTCACTGAT Intergenic TTHA0056 1/4 










34a Chromosome 1,292,459 1,292,480 2.35x10-5 1 CATGGTGAGCATGATGACCTTG Intragenic TTHA1352 1/3 
34b Chromosome 1,292,459 1,292,480 2.35x10-5 1 CAAGGTCATCATGCTCACCATG Intragenic TTHA1353 1/2 
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35a Chromosome 472,200 472,221 2.44x10-5 1 CCCTGTTTTTCAAGATACAAAA  Intragenic TTHA0506 1/1 
35b Chromosome 472,200 472,221 2.44x10-5 1 TTTTGTATCTTGAAAAACAGGG Intragenic TTHA0507 1/1 
36a Chromosome 550,760 550,781 2.62x10-5 1 AAAAGGGGGCCAGGGCACTTTT  Intergenic TTHA0583 1/1 
36b Chromosome 550,760 550,781 2.62x10-5 1 AAAAGTGCCCTGGCCCCCTTTT Intergenic TTHA0584 1/1 
37a Megaplasmid 79,603 79,624 2.84x10-5 1 CAGGGTGAGGGGGAGCACATTC Intergenic TTHB088 1/1 
37b Megaplasmid 79,603 79,624 2.84x10-5 1 GAATGTGCTCCCCCTCACCCTG Intergenic TTHB089 1/3 










40a Chromosome 574,514 574,535 3.32x10-5 1 TAAACTAAGAAAGTTTACGAAA Intergenic TTHA0606 1/2 
40b Chromosome 574,514 574,535 3.32x10-5 1 TTTCGTAAACTTTCTTAGTTTA Intergenic TTHA0607 1/1 





42a Chromosome 290,819 290,840 3.58x10-5 1 TATAGTGAGGTATGGTCCGGTT Intragenic TTHA0303 1/1 
42b Chromosome 290,819 290,840 3.58x10-5 1 AACCGGACCATACCTCACTATA Intragenic TTHA0304 1/3 






















47 Chromosome 1,546,227 1,546,248 4x10-5 1 CATTGACTTTATGCTCACCATC Intragenic TTHA1632 2/2 
48 Chromosome 871,788 871,809 4.26x10-5 1 CTTTGGGCTTTGAAAAACAAAG Intergenic TTHA0910 3/3 












51a Chromosome 574,529 574,550 4.74x10-5 1 GTTCGTAAACCAAAATAAACTA Intergenic TTHA0606 1/2 
51b Chromosome 574,529 574,550 4.74x10-5 1 TAGTTTATTTTGGTTTACGAAC Intergenic TTHA0607 1/1 





53 Chromosome 32,413 32,434 4.94x10-5 1 CAAGGTGAAGGACGTCACCAAG Intragenic TTHA0030 1/2 
54 Chromosome 37,707 37,728 4.94x10-5 1 CAAGGTGAAGGACGTCACCAAG Intragenic TTHA0036 1/3 





56a Chromosome 1,332,409 1,332,430 5.15x10-5 1 CCATGTGCCCAAGTATACTTAG Intragenic TTHA1398 1/1 
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56b Chromosome 1,332,409 1,332,430 5.15x10-5 1 CTAAGTATACTTGGGCACATGG Intragenic TTHA1399 1/1 
57a Chromosome 203,014 203,035 5.48x10-5 1 TTGTGTAAAAATGCGCACCATG Intragenic TTHA0205 1/3 
57b Chromosome 203,014 203,035 5.48x10-5 1 CATGGTGCGCATTTTTACACAA Intragenic TTHA0206 1/3 
58 Chromosome 738,907 738,928 5.71x10-5 1 CATTGTGCCCCGGGGTGCCTTT Intergenic TTHA0770 1/2 
59 Chromosome 1,075,413 1,075,434 5.75x10-5 1 AAATGTCCCAAAAAGTCCCTTT Intergenic TTHA1133 1/3 
P-value indicates the FIMO calculated probability of random sequence of input motif length fitting the identified potential binding 
site sequence equally well or better than the input motif. Q-value indicates the rate of false discovery for potential binding sites 
considered important. Operon indicates the position of the gene within its transcribed unit. 
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Figure 11. Bioinformatically characterized TTHA1359-binding sites in the T. thermophilus 
HB8 genome with regulatory potential. Sequences depict the genomic sequence context, -
210/+310 bp, of the refined twenty-three FIMO-identified TTHA1359-binding sites 
analyzed for potential regulatory functions. Blue, red, green, and black nucleotides represent 
genes oriented 5’→ 3’, overlapping genes oriented 5’→ 3’, genes oriented 5’→ 3’ on the 
complementary strand, and intergenic regions respectively. Cyan, yellow, and green 
highlighting represent predicted core promoter elements, potential TTHA1359-binding sites, 
and potential TTHA1359-binding sites overlapping core promoter elements respectively. 






























Potential Binding Site 






2 TTHA0953 -74.5 3 N - 
4 TTHA0425 -41.5 0  Y Activating, Class II 
6 TTHA0987 -82.5 0 Y Activating Class I 
8a TTHA0446 -65.5 4 N - 
8b TTHA0447 -38.5 3 N - 
14a TTHA0533 -44.5 3 N - 
35a TTHA0506 -61.5 0 Y Activating, Class I 
36b TTHA0584 -41.5 0 Y Activating, Class II 
37b TTHB089 -93.5 1 Y Activating, Class I 
40a TTHA0606 -58.5 3 N - 
51a TTHA0606 -73.5 2 N - 
57b TTHA0206 -99.5 3 N - 
58 TTHA0770 -41.5 0 Y Activating, Class II 
Phase indicates the alignment of potential binding sites in relation to predicted core 
promoter elements. A phase of 0 indicates sites are aligned. Other phase numbers 
indicate sites are unaligned and by how many bp they are out of alignment. Potential 
sites were considered likely (Y) or unlikely (N) to function as regulatory sites based 
on phase alignment.78,79 Potential mechanisms associated with identified potential 
regulatory TTHA1359-binding sites were described as Activating, Class I if sites 
were positioned upstream of predicted -35 elements and Activating, Class II if sites 




CHAPER 4. DISCUSSION 
 In the Van Dyke laboratory, a reverse-genetic technique involving the 
combinatorial selection technique REPSA has been applied to study the possible 
regulatory and biological roles of TFs by identifying their DNA-binding specificities and 
the potential genes they regulate.19-22 Since many TFs lack a level of characterization 
beyond a mere family categorization, an end goal in the Van Dyke laboratory is to 
implement this reverse-genetic technique as an effective alternative to other methods 
used to study putative TFs. Previously, this reverse-genetic technique had been applied 
to study the DNA-binding specificities and potential genes regulated by four T. 
thermophilus HB8 transcriptional repressors.19-22 These TFs were specifically selected to 
study using this reverse-genetic technique because they possessed a pre-existing level of 
regulatory and biological characterization.14,15,17,18 This allowed the findings from the 
reverse-genetic studies of these TFs to be compared to previously reported findings to 
evaluate the effectiveness of the reverse-genetic technique.14,15,17-22 In general, the 
reverse-genetic studies with these four TFs not only corroborated previous findings but 
also reported additional findings which further characterized these TFs.14,15,17-22 In the 
present work, several steps in the application of this reverse-genetic technique to identify 
the possible regulatory and biological roles of the previously studied T. thermophilus 
HB8 transcriptional activator TTHA1359 have been described as part of yet another 
study to evaluate the effectiveness of this reverse-genetic technique.12,13 
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 The DNA-binding consensus 5’-A(T/A)TGT(G/A)A(N6)T(C/T)ACA(A/T)T-3’ 
was identified for TTHA1359 using REPSA to select sequences preferentially bound by 
TTHA1359, massively parallel sequencing to acquire the sequence information of these 
selections, and MEME to elucidate TTHA1359-binding motifs from obtained sequence 
information. Previous studies with TTHA1359 initially identified sixteen gene promoters 
which were upregulated in the presence of TTHA1359.12,13 Eight of these promoters 
were initially identified through differential gene expression levels obtained from wild-
type and TTHA1359-inactivated T. thermophilus HB8 strains.12 The other eight gene 
promoters were initially identified by analyzing gene expression levels obtained from 
various experiments with T. thermophilus HB8 strains for individual genes whose 
expression showed strong positive correlations with TTHA1359 expression.13 After 
validating that these sixteen gene promoters were upregulated in a TTHA1359-
dependent mechanisms in run-off transcription assays in vitro, putative TTHA1359-
binding sites were assigned to these sixteen gene promoter sequences from which the 
putative consensus TTHA1359-binding site 5’-TTGTG(N9)CNC-3’ was derived.
12,13 
Comparing this consensus to the consensus identified for TTHA1359 in the present work 
reveals a partial overlap between consensus sequences, particularly in the consensus 
composition along the 5’-end of both consensuses.13 While the consensus from the 
previous studies was derived from sixteen predicted TTHA1359-binding sites, the 
TTHA1359-binding consensus in the present work was derived from a motif, primarily 
the top non-palindromic motif, discovered in seven hundred and eighty-nine 
experimentally selected unique sequences.12,13 Therefore, greater confidence is placed in 
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the REPSA-selected TTHA1359-binding consensus as an accurate representation of the 
DNA-binding specificity of TTHA1359.  
 Prior to bioinformatically applying the TTHA1359-binding consensus identified 
in the present work to identify potential regulatory binding sites for TTHA1359 in the T. 
thermophilus HB8 genome, the consensus was evaluated biophysically by BLI to assess 
its true reflection of intrinsic TTHA1359-DNA binding specificity. This evaluation 
included testing not only TTHA1359-binding to the identified consensus but also to 
single-point and spacing mutants of the consensus to probe this specificity. TTHA1359 
was observed to bind with high affinity, apparent KD of ~ 3.4 nM, to the identified 
consensus, and single-point mutations to the consensus were found to lower this high 
binding affinity (Table 1). Of the single-point mutations to the consensus tested, some 
were found to dramatically reduce this binding affinity with no significant or detectable 
binding having transpired under the reaction conditions applied while others were found 
to reduce this binding affinity less radically with apparent KD values ranging from ~ 23 
to ~ 86 nM (Table 1). These single-point mutations were found to reduce TTHA1359-
binding affinity in a method that reflected the significance of the positions in the 
TTHA1359-binding consensus as indicated by the top MEME non-palindromic motif 
(Figure 9A1, Table 1). Additionally, consensus spacing mutations were observed as 
having no significant or observable binding which suggests that TTHA1359 possesses a 
stringent consensus spacing requirement for recognition (Table 1). Because BLI assays 
were limited by the instrument to temperatures considered non-native for the protein, 
37°C as opposed to at least 47°C, this consensus spacing requirement might merely 
reflect an experimental constraint.81,82 Higher temperatures might introduce a level of 
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flexibility within the TTHA1359 dimer which might allow TTHA1359 to recognize 
shorter or lengthier consensus spacer sequences. With an apparent KD of ~ 1 nM, the 
CRPEc consensus was the only sequence tested that exhibited higher binding affinity than 
that of the identified TTHA1359-binding consensus (Table 1). Because of a significant 
degree of consensus conservation between the tested TTHA1359-binding and CRPEc-
binding consensus sequences, the higher binding affinity observed for the CRPEc-binding 
consensus was considered the cumulative result of differences between the two 
sequences (Figure 5A2, 9C, Table 1).63 These differences included the 6-bp spacer 
sequences of these consensuses, 5’-TCTAGA-3’ in the CRPEc consensus sequence as 
opposed to 5’-CACACA-3’ in the TTHA1359 consensus sequence, and single bp 
differences in the half-sites between consensus sequences (Figure 5A2, 9C, Table 1).63 
Together, these kinetic experiments support an accurate reflection of preferred 
TTHA1359-DNA binding in the REPSA-selected TTHA1359-binding consensus.  
 Curiously, in vitro run-off transcription assays which were performed to 
demonstrate TTHA1359-dependent transcriptional upregulation at the promoters 
identified in previous studies utilized a concentration of 1 μM TTHA1359 dimer.12,13 
Results of these run-off transcription experiments were either black or white with an 
observed upregulation of transcription observed in reactions containing TTHA1359.12,13 
The relatively high concentration of TTHA1359 protein in these reactions solicited 
initial concern as BLI experiments in the present work suggest that TTHA1359 possesses 
a low level of binding specificity.12,13 This was suggested by individual single-point 
mutant consensus experiments which found that TTHA1359-binding to its consensus 
sequence had an apparent KD that was minimally ~ 8-fold higher than that of mutant 
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consensus sequences (Table 1). Additionally, a binding event between TTHA1359 and a 
control sequence was detected by BLI at 461 nM TTHA1359 dimer, the highest 
concentration of TTHA1359 protein used in BLI experiments (data not shown). Whether 
this interaction was specific or non-specific was not ascertained. Previously, the 
expression level of TTHA1359 in the stationary phase had been reported measuring 
minimally ~ 8.5-fold higher than that of TTHA1359 in the exponential phase of wild-type 
T. thermophilus HB8 growth during cultivation in different growth media.12 However, a 
high concentration of expressed TTHA1359 transcripts might not necessarily correlate 
with a high concentration of translated TTHA1359 protein. Based on the present work, 
concentrations of 1 μM TTHA1359 dimer used in previous studies to validate 
TTHA1359-dependent transcriptional regulation were initially considered excessive, 
resulting in false positive indications of regulation by TTHA1359 from non-specific 
binding driven by high protein concentrations.12,13 
 However, results of run-off transcription assays performed with TTHA1359 and 
increasingly shorter promoter sequences upstream of genes TTHA0337 and TTHA0634 
suggested the presence of specific promoters sequences essential to the TTHA1359-
dependent transcriptional upregulation of these gene promoters.12 These reported results 
were baffling considering the predicted binding sites for TTHA1359 upstream of these 
genes, 5’-AGGGGAACCCACGGCACAC-3’ and 5’-TTGTGCCTTTTACCCCT-3’ 
respectively, were very different from the REPSA-selected TTHA1359-binding 
consensus.12 As a result of the observed phenomenon, a hypothesis was formulated with 
regard to TTHA1359 transcriptional activity. If TTHA1359-binding conveys insufficient 
specificity to discriminately upregulate transcription, then perhaps a second mechanism 
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conveys further specificity. Since similarities have been reported for structures of 
TTHA1359 and CRPEc and drastically different binding affinities have been reported for 
CRPEc and its consensus compared to one of its most well-understood regulatory binding 
sites, studies with CRPEc were investigated for a potential answer.
12,63 
  As it happens, simple CRPEc-dependent transcriptional activation at promoters 
has been reported to be dependent upon the positioning of binding sites for CRPEc 
relative to core promoter elements.78,79 Studies in which a binding site for CRPEc was 
displaced at increasingly lengthier distances from the -35 core promoter element 
suggested a loss followed by a return of transcriptional activity depending on the 
distance introduced from the initial site of activity.78,79 Spacing mutants for which 
transcriptional activity was lost corresponded to spacer sequences resulting in partial or 
half-turns of the DNA double-helix while activity was returned for spacer sequences 
resulting in full or nearly-full turns of the DNA, positioning CRPEc interactions with 
RNA polymerase holoenzyme out of or into alignment with core promoter elements 
respectively.75,78,79  
 Provided the importance of spacing for simple CRPEc-dependent transcriptional 
activation, a spacing requirement was imposed during the search for potential regulatory 
TTHA1359-binding sites based on distances from predicted core promoter elements. 
Initially, eighty-eight potential TTHA1359-binding sites within the T. thermophilus HB8 
genome were identified. Of these, the first fifty-nine were selected for further 
investigation, totaling seventy-four potential binding sites when sites positioned near 
bidirectionally-oriented promoters with dual regulatory potential were accounted (Table 
2). These potential sites were narrowed down to twenty-three TTHA1359-binding sites 
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with regulatory potential based on several criteria including the presence of predicted 
core promoter elements, the positioning of these promoter elements relative to translation 
start sites of local genes, and positioning of potential TTHA1359-binding sites relative to 
these promoter elements (Figure 11). Since the criteria for reducing the number of 
potential regulatory TTHA1359-binding sites revolved to a large extent around predicted 
core promoter elements, several potential regulatory binding sites for TTHA1359 might 
have been missed due perhaps to the inability to predict core promoter elements or the 
inaccurate prediction of core promoter element positioning. This is a current limitation of 
the reverse-genetic technique resulting from the orientation of promoter prediction 
software to predict core promoter elements based on those recognized by the 
housekeeping RNA polymerase holoenzyme in E. coli and not that of T. thermophilus.90 
While attempts by the Van Dyke laboratory are being made to more accurately predict 
and map T. thermophilus core promoter elements, the promoter prediction software used 
in this study was currently considered the best option to predict promoters with a user-
defined restriction as to the allowable distance between predicted transcription and 
translation start sites. 
 Of the twenty-three refined TTHA1359-binding sites with regulatory potential, 
thirteen of the twenty-three were positioned upstream of predicted -35 core promoter 
elements with the potential to function as transcriptional activation binding sites for 
TTHA1359 (Table 3). However, only five of these thirteen potential TTHA1359-binding 
sites were positioned optimally upstream to activate transcription at gene promoters 
(Table 3). These five potential binding sites corresponded to those found upstream of 
genes TTHA0425, TTHA0506, TTHA0584, TTHA0770, and TTHA0987. A sixth potential 
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activating site for TTHA1359 was found upstream of TTHB089, but this site was 
considered unlikely to lead to substantial upregulation of TTHB089 by TTHA1359 (Table 
3). The eight remaining upstream potential sites were positioned poorly, oriented along 
different or opposite faces of the DNA double-helix as core promoter elements (Table 3). 
These potential TTHA1359-binding sites were considered unlikely to upregulate 
transcription of local downstream gene promoters. As a point of interest, the remaining 
ten potential binding sites overlapped the core promoter elements in a manner suggestive 
of transcriptional repression. Because previous studies with TTHA1359 only reported its 
activity as a transcriptional activator, the role of these sites has yet to be determined.12,13 
  In contrast to the absence of previous findings supporting a role for TTHA1359 
as a transcriptional repressor, ample findings have been reported supporting the role of 
TTHA1359 as a transcriptional activator.12,13 TTHA1359 has been demonstrated to 
upregulate transcription from promoters upstream of the sixteen genes TTHA0425, 
TTHA0654, TTHA0337,  TTHA0986, TTHA0770, TTHA1028, TTHA0634, TTHA0570, 
TTHA0557, TTHA0029, TTHA1128, TTHA1215, TTHA1625, TTHA1635, TTHA1892, 
and TTHB132 in run-off transcriptional assays in vitro.12,13 Comparing these genes to 
potentially regulated genes identified in the present work, TTHA0425, TTHA0506, 
TTHA0584, TTHA0770, and TTHA0987, suggests the overlapping identification of only 
the two genes TTHA0425 and TTHA0770.12,13 A third gene, TTHA0987, would have 
overlapped the genes identified in both studies had it not failed to be validated in a 
previous study.13 Previous TTHA1359 studies predicted TTHA1359-binding sites within 
~ 30-50 bp of transcription start sites, positions suggestive of Class II transcription 
activation binding sites for TTHA1359.12,13 However, in the case of the TTHA0987 gene 
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promoter as determined in the current study, the TTHA1359 binding site maps to ~ 82 bp 
upstream of the transcription start site, indicative of a Class I transcriptional activation 
binding site for TTHA1359. Analyzing the run-off transcription template promoter 
sequence utilized to test TTHA0987 promoter regulation by TTHA1359 in the previous 
study suggested the TTHA1359-binding site identified in the present study had been 
occluded by 20 bp.13 This was considered the likely reason why the TTHA0987 gene 
promoter failed to be validated in the previous study.13 Interestingly, the TTHA0987 gene 
promoter might be coregulated by TTHA1359 and TTHB032, a previously studied 
transcriptional repressor in the Van Dyke laboratory, based on potential regulatory 
binding sites for both TFs identified in the TTHA0987 gene promoter.17,22  
 Of the five genes potentially activated by TTHA1359 based on optimally 
positioned potential regulatory binding sites in their promoters, the genes TTHA0506 and 
TTHA0584 appear to be novel genes which could have been missed in previous 
studies.12,13 These sites could have been missed in previous genetic studies due to 
occlusion of these binding sites by chromosome organization or the activity of 
transcriptional repressors interfering with the activation of TTHA0506 and TTHA0584 
gene promoters.12,13 Regarding the remaining fourteen TTHA1359-regulated genes 
identified in previous studies with TTHA1359, these sites could have been missed using 
the reverse genetic technique due to promoter prediction limitations mentioned in a 
preceding paragraph or the limited number of FIMO-identified results investigated.12,13 
To test the latter possibility, the extended TTHA1359-binding consensus motif created 
should be applied using FIMO to search the promoter sequences of these fourteen genes 
used in run-off transcription assays in previous studies.12,13 Identified TTHA1359 motif 
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matches within these promoter sequences should then be searched within the list of 
potential TTHA1359-binding sites in the T. thermophilus HB8 genome initially 
identified by FIMO using the extended TTHA1359-binding consensus motif. The initial 
FIMO scan could be expanded, if necessary, by resubmitting the initial search with a 
lower p-value threshold for matches to the TTHA1359-binding consensus. Identifiable 
since on the list would support that the missed genes reported in previous studies could 
have been identified as genes potentially activated by TTHA1359 using the reverse-
genetic technique if more FIMO-identified sites would have been investigated.12,13  
 As the present work served as an additional test as to the effectiveness of a 
reverse-genetic technique involving REPSA to study TFs, a conclusion of the present 
work without evaluating the effectiveness of this reverse-genetic technique would leave 
the present work incomplete. Based on the findings of the current study, applying a 
reverse-genetic methodology involving REPSA alone to study global transcriptional 
activators appears inadequate to the task. A strength of the genetic approach previously 
applied to study TTHA1359 was the apparent in vivo identification of genes whose 
promoters were potentially regulated by TTHA1359 which allowed run-off transcription 
assays to be performed in vitro to validate TTHA1359-dependent regulation of the 
identified promoters.12,13 In some instances, a genetic approach such as the approaches 
used to study TTHA1359 might miss potentially regulated genes.12,13 Such a case is 
demonstrated by the T. thermophilus HB8 gene TTHA0987 which was identified as 
potentially regulated by TTHA1359 but not validated for TTHA1359-dependent 
transcriptional upregulation previously.13 Additionally, genes, potentially including 
TTHA0506 and TTHA0584 identified in the present work, might be missed due to other 
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factors complicating genetic approaches to studying TFs which have been mentioned 
previously. However, the genetic approaches used to study TTHA1359 identified more 
genes under the control of TTHA1359 than the reverse-genetic technique used in the 
present work.12,13 Strengths of the reverse-genetic technique include the ability to 
characterize the intrinsic DNA-binding specificity of TFs and biophysically characterize 
TF-DNA interactions.19-22 However, as suggested in the present work with TTHA1359, 
identifying potential regulatory binding sites within genomes based on statistically 
significant matches to the DNA-binding consensuses of TFs does not account for 
additional mechanisms such as binding site spacing from core promoter elements which 
might prove more critical to the regulatory roles of TFs than these matches. A 
combinatorial approach, understanding the DNA-binding specificity of TFs and 
application of such understanding to validate potentially regulated gene promoters 
identified by a genetic approach might prove a more effective method. However, since 
TTHA1359 functions as a global activator, it might represent a special case.12,13  
 Finally, a few future directions for the project have been described. Future work 
should seek to validate whether TTHA1359 upregulates the transcription of TTHA0506 
and TTHA0584 which were genes not previously identified in previous studies with 
TTHA1359.12,13 In vitro run-off transcription assays could be used to validate these 
genes as with the genes in previous TTHA1359 studies.12,13 Additionally, an in vitro run-
off transcription assay with the TTHA0987 gene promoter should be performed 
incorporating both TTHA1359 and TTHB023 to determine whether coregulation of this 
gene occurs as suggested by prior work and the present study.22 The fourteen 
TTHA1359-regulated genes reported in previous studies but missed in the present work 
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should be investigated for potential TTHA1359-binding sites using FIMO and the 
extended TTHA1359-binding motif to identify whether these genes would have been 
identified if more FIMO-identified matches were investigated.12,13 Potential regulatory 
binding sites for TTHA1359 which were found to overlap predicted core promoter 
elements should be examined more closely to identify the potential regulatory roles of 
these sites. This might be accomplished by obtaining the TTHA1359-inactivated and 
wild-type T. thermophilus HB8 gene expression levels collected previously for genes 
downstream of these sites to provide insight into their potential regulatory roles.12,13  
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APPENDIX A: OLIGONUCLEOTIDES 
 
Length is reported in nucleotides (nt). 
Name Sequence Length Purification Application 
ST2R24 CTAGGAATTCGTGCAGAGGTGAATNNNNNNNNNNNNNNNNNNNNNNNNTTACCATCCCTCCAGAAGCTTGGAC 73 PAGE Selection Template ST2R24 Precursor 
ST2L CTAGGAATTCGTGCAGAGGTGAAT 24 Desalt PCR Primer 
ST2Ls CTAGGAATTCGTGCAGAGGTGA 22 Desalt PCR Primer 
IRD7_ST2R /5IRD700/GTCCAAGCTTCTGGAGGGATGGTAA 25 HPLC 5’-labeled IRDye700 PCR Primer 
A_BC06_ST2R CCATCTCATCCCTGCGTGTCTCCGACTCAGCTGCAAGTTCGATGTCCAAGCTTCTGGAGGGATG 64 PAGE Fusion PCR Primer 
trP1_ST2L CCTCTCTATGGGCAGTCGGTGATCTAGGAATTCGTGCAGAGGTGA 45 PAGE Fusion PCR Primer 
A_uni CCATCTCATCCCTGCGTG 18 Desalt PCR Primer 
trP1_uni CCTCTCTATGGGCAGTCGG 19 Desalt PCR primer 
Bio_ST2R /5BiodT/GTCCAAGCTTCTGGAGGGATG 22 HPLC 5’-biotinylated PCR primer 
ST2_1359_ctrl CTAGGAATTCGTGCAGAGGTGAATACGAAAAACACACACCATCCCTCCAGAAGCTTGGAC 60 Desalt TTHA1359 Control Probe Precursor 
ST2_1359_con_wt GGAATTCGTGCAGAGGTGAATTGTGACACACATCACAATCATCCCTCCAGAAGCTTGG 58 Desalt Wild-type TTHA1359 Consensus Probe Precursor 
ST2_1359_con_p1 GGAATTCGTGCAGAGGTGACTTGTGACACACATCACAATCATCCCTCCAGAAGCTTGG 58 Desalt 
TTHA1359 Consensus Position 1 Point Mutation  
Probe precursor 
ST2_1359_con_p2 GGAATTCGTGCAGAGGTGAAGTGTGACACACATCACAATCATCCCTCCAGAAGCTTGG 58 Desalt 
TTHA1359 Consensus Position 2 Point Mutation  
Probe Precursor 
ST2_1359_con_p3 GGAATTCGTGCAGAGGTGAATGGTGACACACATCACAATCATCCCTCCAGAAGCTTGG 58 Desalt 
TTHA1359 Consensus Position 3 Point Mutation  
Probe Precursor 
ST2_1359_con_p4 GGAATTCGTGCAGAGGTGAATTTTGACACACATCACAATCATCCCTCCAGAAGCTTGG 58 Desalt 
TTHA1359 Consensus Position 4 Point Mutation  
Probe Precursor 
ST2_1359_con_p5 GGAATTCGTGCAGAGGTGAATTGGGACACACATCACAATCATCCCTCCAGAAGCTTGG 58 Desalt 
TTHA1359 Consensus Position 5 Point Mutation 
 Probe Precursor 
ST2_1359_con_p6 GGAATTCGTGCAGAGGTGAATTGTTACACACATCACAATCATCCCTCCAGAAGCTTGG 58 Desalt 
TTHA1359 Consensus Position 6 Point Mutation  
Probe Precursor 
ST2_1359_con_p7 GGAATTCGTGCAGAGGTGAATTGTGGCACACATCACAATCATCCCTCCAGAAGCTTGG 58 Desalt 
TTHA1359 Consensus Position 7 Point Mutation 
Probe Precursor 
ST2_1359_con_s5 GGAATTCGTGCAGAGGTGAATTGTGACACACTCACAATCATCCCTCCAGAAGCTTGG 57 Desalt 
TTHA1359 Shortened Spacer Consensus Mutation 
Probe Precursor 
ST2_1359_con_s7 GGAATTCGTGCAGAGGTGAATTGTGACACACACTCACAATCATCCCTCCAGAAGCTTGG 59 Desalt 
TTHA1359 Lengthened Spacer Consensus Mutation 
Probe Precursor 
ST2_CRP_Ec GGAATTCGTGCAGAGGTGAAATGTGATCTAGATCACATTTCATCCCTCCAGAAGCTTGG 59 Desalt E. coli CRP Consensus Probe Precursor 
Table A1. Oligonucleotides 
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Figure B1. Additional BLI association and dissociation step raw data plots of TTHA1359-DNA binding. Graphs depict raw association and 
dissociation step data measured during BLI experiments with TTHA1359 and (A) ST2_1359_con_p1, (B) ST2_1359_con_p2, (C) 
ST2_1359_con_p3, (D) ST2_1359_con_p4, (E) ST2_1359_con_p5, (F) ST2_1359_con_p6, and (G) ST2_1359_con_p7 biotinylated DNAs. 
These DNAs correspond to TTHA1359-binding consensus sequences containing single point mutations at position 1, 2, 3, 4, 5, 6, and 7 
respectively. Graphs also depict the raw step data measured during BLI experiments with TTHA1359 and (H) ST2_1359_con_s5 and (I) 
ST2_1359_con_s7 biotinylated DNAs. These DNAs correspond to TTHA1359-binding consensus sequences containing 5- and 7-bp spacer 
sequences respectively instead of the 6-bp spacer of the wild-type TTHA1359-binding consensus. Dots represent raw data points, and solid lines 
depict the calculated best-fit lines for these raw data points. Line colors pink, green, orange, and blue indicate different concentrations of 
TTHA1359 protein corresponding to 5.7, 17, 51, and 153 nM TTHA1359 dimer. 
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APPENDIX C: BIOINFORMATICALLY CHARACTERIZED TTHA1359-BINDING 































































































































































































































































































































































































































































































































































































































































Figure C1. Bioinformatically characterized potential TTHA1359-binding sites within the T. 
thermophilus HB8 genome excluded from analysis. Sequences depict the genomic context of 
potential binding sites, -210/+310 bp, identified by FIMO which were excluded from further 
analysis. Blue, red, green, and black nucleotides represent genes oriented 5’→ 3’, overlapping 
genes oriented 5’→ 3’, genes oriented 5’→ 3’ on the complementary strand, and intergenic 
regions respectively. Cyan, yellow, and green highlighting represent predicted core promoter 
elements, potential TTHA1359-binding sites, and potential TTHA1359-binding sites overlapping 
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